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ABSTRACT 
 
Background. The protein components of eukaryotic cells face acute and chronic 
challenges to normal folding, refolding and function owing to a constant barrage of 
physical, metabolic and environmental stresses.  Eukaryotic protein homeostasis, 
or proteostasis, enables healthy cell adaptation during development and protects 
against  aging and diseases. Proteostasis refers to controlling the concentration, 
conformation, binding interaction and location of individual proteins making up the 
proteome by readapting the innate biology of the cell, often through transcriptional 
and translational changes. The endoplasmic reticulum (ER) responds to the 
accumulation of unfolded proteins in its lumen (ER stress) by activating 
intracellular signal transduction pathways, cumulatively called the unfolded protein 
response (UPR). The UPR activation triggers an extensive transcriptional and 
translational response, which adjusts the ER protein folding capacity according to 
needs. As such, the UPR constitutes  one of the signaling pathways that  regulates  
the capacity and composition of the proteostasis network  according to the 
changing of the  ER folding capacity.   
Previous work. My initial work, described in chapter 1.2.1 shows that the level of 
cellular energy is important for protein folding and  disaggregation and thus can 
affect folding and repair processes. 
The proteostasis network is not only highly adaptable, enabled by the influence of 
multiple cell stress signaling pathways, but also can be quite distinct in each cell 
type. In chapter 1.2.2, by using as a cellular model the plasma cells differentiation, 
I could underline the role of the UPR signaling and proteasomal degradation in 
orchestrating the architectural and functional changes of the cells and balancing 
the proteostasis capacity.  
Recent studies suggest that lack/decrease of O2 perturbs  the ER homeostasis. 
Indeed the ER has emerged as a cellular compartment that depends on O2 for 
oxidative folding of secretory and transmembrane proteins and that mediates the 
O2 signaling that is important for the survival and function of hypoxic cells. In vitro 
studies have shown that  hypoxia  triggers the UPR. However, in vivo and in vitro 
situations are indeed likely to diverge substantially with respect to parameters such 
as metabolic activity, O2 utilization and cell division rates, features that are 
predicted to vary the cell sensitivity to ER stress.  Thus, despite a recognized role 
for hypoxia on UPR, few data exist on the effects of hypoxia in various organs in 
vivo. 
Aims. My study includes three aims: First, we will test if the hypoxic stress in vivo 
acts as a modifier that  affects the activation of specific branches of the UPR in 
different tissues. Second, to get a better insight into the role of the UPR during low 
oxygen availability in tissues, we will test whether the UPR activation depends from 
the severity of the hypoxic stress. Third, we aim at delineating  signaling circuits 
that control the capacity and composition of the proteostasis network  through 
transcriptional and post transcriptional mechanisms to balance the ER 
homeostasis 
Results. I analyzed the effect of the hypoxic stress on the proteostasis network. 
Changes in O2 levels alter the ability of the cells to handle the proteostasis load 
with some differences between the cells type studied. Hepatocytes and myocytes 
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respond to hypoxia by increasing their degradation activity as to increase the 
proteostasis capacity. While the hepatocytes activate an UPR-dependent 
apoptosis and are able to balance between apoptotic death and protein synthesis, 
in the myocytes the protein synthesis remains sustained under low oxygen 
availability while the UPR –dependent apoptosis could not be detected. 
Conclusion.  This studies underlined several features of the ER- proteostasis. 
First, the proteostasis network is adaptable and able to fine tune the UPR signaling 
pathway in response to stress. Second, different cells have varying proteostasis 
capacities reflected in the composition and concentrations of their proteostasis 
components. Third, within a given cell type, the proteostasis does not possess 
significant excess capability, rater it is finely tuned and offers just enough facility for 
the protein folding load. Therefore, by setting the proteostasis boundary as a 
threshold for generating folded and functional proteins, the proteostasis network 
can create and maintain functional proteins in response to the local environment 
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RIASSUNTO 
 
Introduzione. Le proteine delle cellule eucariotiche devono affrontare  continue  
difficolta’ durante il processo di ripiegamento conformazionale  ed espletamento 
delle loro funzioni biologiche dovuti a stress cellulari di tipo fisico, metabolico e 
ambientale. 
L’omeostasi delle proteine, detta proteostasi, permette l’adattamento cellulare 
durante lo sviluppo e protegge la cellula dall’invecchiamento e dallo stress. Il 
termine proteostasi si riferisce al controllo della concentrazione, conformazione, 
interazione e localizzazione delle proteine facenti parte del proteoma  per 
permettere alla cellula di adattarsi alle mutate condizioni attraverso cambiamenti 
trascrizionali e traduzionali. Il reticolo endoplasmico  (ER) risponde all’accumulo 
delle proteine misfoldate nel proprio lume ( ER stress) attivando segnali  
intracellulari complessivamente chiamati Unfolded Protein Response (UPR). 
L’attivazione dell’ UPR induce una risposta sia  trascrizionale che traduzionale che 
mira ad aumentare la capacita’ di ripiegamento delle proteine dell’ER per 
commensurarla alle nuove necessita’ cellulari. In questo modo la cellula adegua la 
sua capacita’ di sintesi e ripiegamento delle proteine secretorie a seconda delle 
proprie necessita’. 
Lavoro iniziale. Il lavoro iniziale, descritto nel capitolo 1.2.1 dimostra che il livello 
di energia intracellulare è importante per il corretto ripiegamento proteico e per il 
recupero di proteine aggregate per cui influenza  i processi sia di ripiegamento che 
di riparazione. L’insieme delle proteine che regolano l’omeostasi cellulare è molto 
adattabile, grazie alla presenza di diverse vie di segnale, e possiede caratteristiche 
distinte per tipi cellulari. Usando come modello la differenziazione delle plasma 
cellule nel ho potuto delineare il ruolo dell’UPR  e della degradazione 
proteasomale nella regolazione dei cambiamenti strutturali e funzionali. (capitolo 
1.2.2) 
Studi recent suggeriscono che la mancanza o ridotta concentrazione cellulare di 
ossigeno modifica la proteostasi dell ER. Infatti il processo di ripiegamento 
ossidativo delle proteine transmembrana e secretorie dipende dalla 
concentrazione di ossigeno intracellulare e segnali cellulari vengono attivati in 
situazioni di ridotta concentrazione di O2  importanti per il processo di 
sopravvivenza delle cellule ipossiche. Studi condotti in vitro hanno dimostrato che 
l’ipossia attiva l’UPR. Tuttavia analisi condotte in vitro e in vivo possono differire 
rispetto alcuni parametri come l’attività metabolica, l’utilizzo di O2  e la divisione 
cellulare, caratteristiche che variano la capacità delle cellule di gestire lo stress. 
Per cui le situazioni in vitro possono essere diverse da quelle in vivo. 
Scopo. Il mio studio include 3 ipotesi. Primo analizzerò se lo stress ipossico in vivo 
attiva l’UPR o parte di esso in diversi tessuti. Secondo testerò se l’attivazione 
dell’UPR dipende dall’intensita’ dello stress. Terzo mi propongo di delineare le vie 
di segnale che controllano la capacita’ e la composizione dell’insieme di proteine 
che governano l’omeostasi cellulare. 
Risultati.  Ho  analizzato l’effetto dell’ipossia sulla proteostasi del reticolo. Le 
cellule rispondono in modo diverso alle alterate disponibilita’ di ossigeno cellulare a 
seconda della loro capacita’ di adeguamento alla alterata omeostasi delle proteine. 
Sia gli epatociti che i miociti cardiaci aumentano l’attivita’ di degradazione proteica 
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durante l’ipossia in modo da aumentare le capacita’ proteostatiche. Inoltre gli 
epatociti attivano sia segnali di attenuazione della sintesi proteica che di apoptosis. 
Conclusione. Questi  studi hanno permesso di individuare diverse caratteristiche 
del processo omeostatico dell’ER. Primo,  la proteostasi delle proteine  e’ 
adattabile e in grado attivare processi di UPR in seguito a stress. Secondo, le 
cellule possiedono diverse capacita’ proteostatiche a seconda della loro funzione 
nell’organismo. Terzo, le cellule una limitata capacita’ di ripiegare le proteine in 
eccesso in modo corretto. Quindi le cellule possiedono una specifica delimitata 
capacita’ proteostatica tale da consentirne il funzionamento in risposta all’ambiente 
circostante. 
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XBP1 X-Box Binding Protein 1 
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1.INTRODUCTION 
 
1.1 Background 
 
1.1.1 Protein folding in the endoplasmic reticulum 
 
The endoplasmic reticulum (ER) is an organelle that plays essential roles in 
multiple cellular processes that are required for normal and cellular survival 
functions. These processes include intracellular calcium homeostasis, protein 
folding and trafficking  and lipid biosynthesis, (Anelli and Sitia, 2008), (Pizzo and 
Pozzan, 2007), Rizzuto et al., 2004). 
The lumen of the ER constitutes an unique cellular environment. For instance, the 
ER contains the highest concentration of intracellular Ca
2+
 owing to active transport 
by Ca-ATPases. In addition, because of its role in protein folding and transport, the 
ER is rich in calcium-dependent molecular chaperones.    ER-resident chaperones 
have multiple functions as they help folding  nascent proteins, prevent  unfolded 
proteins from aggregating, help  protein refolding and thus rescue misfolded 
proteins, and sense the levels of accumulating misfolded proteins in the organelle. 
The ER lumen is also an oxidative environment  relative to the cytosol, which is 
crucial for the formation of disulphide bonds in maturing proteins, further stabilizing 
the proteins structure.  Moreover, various post translational modifications of 
proteins, including glycosylation and lipidation, occur in the ER  and serves as 
signal of the protein’s folding state. (Ma and Hendershot, 2004), (Schroder and 
Kaufman, 2005). 
In eukaryotic cells, secreted and transmembrane proteins enter the ER as unfolded 
polypeptide chains;  the flux of proteins entering the ER is variable because it can 
change rapidly in response to cell differentiation, to environmental conditions and 
according to the physiological state of the cell. Because many cell surface proteins 
relay important signals that ultimately determine cell fate, i.e whether a cell is to 
differentiate, divide, migrate, or die, the fidelity of folding and assembly of these 
components is vital for the health of an organism, as a result the ER has to 
constantly asses its folding capacity to meet the cellular needs.  
An imbalance between the load of unfolded proteins that enter the ER and the 
capacity of the cellular machinery that handles this load is called ER stress. ER 
homeostasis can be perturbed by physiological processes such as aging, 
postprandial production of insulin and plasma cells differentiation, as well as by 
pathological processes such as viral infections, environmental toxins, inflammatory 
cytokines (Fig.1). ER stress is also  triggered by conditions that alter proteostasis 
associated with perturbations in protein maturation, expression of certain mutant 
proteins, decreased chaperones function, abnormal ER calcium content, redox 
metabolism and altered protein trafficking (Kaufman, 2002; Kaufman et al., 2002). 
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Fig. 1 The ER homeostasis. The ER homeostasis can be perturbed by 
physiological and pathological stimuli. Disruption of ER homeostasis causes 
accumulation of unfolded and misfolded proteins in the ER. This condition is 
referred as ER stress. 
 
As an initial response to ER stress, cells activate the Unfolded Protein Response 
(UPR) to decrease the unfolded protein load and reestablish  homeostasis. Gene 
expression microarray studies performed in S. cerevisiae showed that the UPR 
signaling enforces global changes in expression of molecules related to nearly 
every aspect of the secretory pathway, as activation of the UPR increases the 
amount of ER membrane and its components, including chaperones and protein 
folding enzymes (Cox et al., 1997). 
In eukaryotes the UPR is initiated by three ER transmembrane proteins, inositol 
requiring 1 (IRE1), protein kinase R-like ER kinase (PERK) and activating 
transcription factor 6 (ATF6). These master regulators sense the protein folding 
conditions and translate this information to the nucleus to regulate downstream 
effectors in order to attenuate stress and to restore homeostasis (Bernales et al., 
2006) (Yoshida et al., 2003). These responses include:  i)  attenuation of protein 
translation to reduce ER workload and prevent further accumulation of unfolded 
proteins; ii) upregulation of molecular chaperones and processing enzymes to 
enhance the ER folding activity;  iii) increased  ER-associated degradation (ERAD) 
components to promote clearance of unfolded proteins by the proteasome 
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(Harding et al., 2000b), (Yan et al., 2002), (Yoshida et al., 2003), (Oyadomari et al., 
2006).  
 
 
 
Fig. 2 The signaling network activated by the UPR. The UPR is initiated by 
three master regulators IRE1, PERK and ATF6. Together these transducers 
regulate different effectors that attenuate ER stress and turn off the UPR when the 
ER homeostasis is restored, balance the survival/death  signaling pathways. 
 
These signaling pathways are not unidirectional as the UPR is equipped with a set 
of effectors that function in negative feedback loops to provide tight control of the 
network, preventing harmful hyperactivation and terminating the signaling  once 
homeostasis is restored (Fig.2). 
Thus the UPR operates as a homeostatic control circuit that regulates the protein 
folding and secretion capacity of the cells according to need. 
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1.1.2  The Unfolding Protein Response signaling pathway  
 
The UPR signaling is initiated by three ER transmembrane sensors, which have 
their luminal portions sensing the protein folding environment in the ER and the 
cytoplasmic effector portions that interact with the transcriptional or translational 
apparatus. The first stress transducer was identified in S. cerevisiae by  screening 
for mutations that block the activation of a UPR-inducible reporter (Cox and Walter, 
1996; Shamu et al., 1994). The gene in question encodes a type 1 ER –resident 
transmembrane protein with a novel luminal domain and a cytoplasmic portion 
containing a protein kinase domain (IRE1) (Cox et al., 1993). In response to the 
accumulation of unfolded proteins, IRE1 oligomerizes allowing for trans-
autophosphorylation of juxtaposed kinase domains. To date it is still debated how 
oligomerization may occur. It has been hypothesized that oligomerization can be 
triggered directly by binding of unfolded proteins to the IRE1 luminal domain, or 
might involve the release of the oligomerization-repressing chaperone GRP78, or 
both (Credle et al., 2005) (Bertolotti et al., 2000; Hetz and Glimcher, 2009; 
Korennykh et al., 2009). 
Activated IRE1 exhibits endoribonuclease activity and mediates the sequence 
specific cleavage of  a single mRNA called X-Box-Binding Protein 1 (XBP1) in 
higher eukaryotes (Shamu et al., 1994), (Calfon et al., 2002).  Spliced XBP1 
(XBP1s) encodes a potent transcriptional activator, (Yoshida et al., 2001), while 
the unspliced XBP1 mRNA encodes XBP1u, an inhibitor of the UPR. IRE1 is 
therefore a bifunctional enzyme, possessing both a protein kinase and a site-
specific endoribonuclease that is regulated by its intrinsic kinase module. In 
addition to post-transcriptional regulation by IRE1, XBP1 is also a transcriptional 
target of the UPR, in fact it has been shown that the levels of XBP1 mRNA 
increase upon UPR induction and continue to rise as ER stress declines and IRE1 
is inactivated (Yoshida et al., 2006). 
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Fig.3 Signaling by IRE1 in stressed cells. IRE1 oligomerizes in the plane of the 
ER membrane. Trans-autophosphorylation in its cytosolic kinase domain unmasks 
its endoribonuclease activity. IRE1 mediates sequence specific cleavage of the 
single known mRNA XBP1, and excises a small RNA intron fragment. The two 
ends of the mRNA are ligated, which leads to a frame shift in the coding sequence. 
Spliced XBP1 mRNA encodes a potent transcriptional activator (XBPs), whereas 
the unspliced XBP1mRNA encodes XBPu, an inhibitor of the UPR. In mammalian 
XBP1 upregulates a set of UPR  genes that promote ER-associated degradation 
(ERAD) of misfolded proteins and ER biogenesis. IRE1 can also recruit TRAF2 to 
signal to JNK and alters intracellular signaling (for example, resulting in insulin 
resistance). The IRE1-TRAF2 complex has been linked to caspase-12 activation 
and cell death. In cultured Drosophila melanogaster cells, activated IRE1 can 
promote the cleavage of various ER-localized mRNAs, leading to their 
degradation,  thus reducing the load on the stressed ER. From Ron, D.  Nature 
Reviews 2007. 
 
 
The ER stress transducer protein kinase RNA (PKR)-like ER-kinase (PERK) 
evolved from IRE1 and their luminal stress-sensing domains are phylogenetically 
related and similar in structure and function (Bertolotti et al., 2000).  The 
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cytoplasmic portion of PERK contains a protein kinase domain which undergoes 
activating trans-autophosphorylation by oligomerization in ER stressed cells. PERK 
phosphorylates the -subunit of the eukaryotic translation initiation factor-2 (eiF2) 
at Ser51; lower levels of eIF2 result in lower translation initiation, globally 
reducing the load of newly synthetized proteins which are destined to enter the 
already stressed ER lumen (Harding et al., 1999). Because other three eIF2 
kinases, triggered either by amino acid starvation, double stranded RNA and heme 
depletion, can activate this pathway independently of ER stress, this portion of the 
UPR is termed the integrated stress response (ISR) (Harding et al., 2003) (Fig. 4). 
Since eIF2 plays a key role in protein translation, cells must tightly regulate the 
level of phosphorylated eIF2 to survive. Two identified genes, GADD34 and 
CReP encode phosphatases that independently dephosphorylate eIF2Bertolotti 
and Ron, 2001; Bertolotti et al., 2000). CReP is constitutively expressed and 
contributes to the baseline eIF2 dephosphorylation, while GADD34 is induced as 
part of the gene expression program activated by eIF2 phosphorylation and 
serves as the negative feedback loop that operates within (Novoa et al., 2001). 
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Fig. 4 Signaling by PERK to the translational machinery and the integrated 
stress response. In response to ER stress PERK oligomerizes and is activated by 
trans-autophosphorylation of its activation loop. Phosphorylation of the single 
known substrate, the alpha subunit of eIF2 on Ser51 inhibits the pentameric 
guanine nucleotide exchange factor eIF2B from recycling eIF2 to its active GTP-
bound form. Other eIF2 kinases (PKR, HRI and GCN2) can activate the pathway 
independently of ER stress, for this reason this portion of the UPR is termed the 
integrated stress response (ISR). Lower global protein synthesis reduces the ER 
unfolded protein load but also affect gene transcription. Translation of ATF4 is 
increased under conditions of limiting eIF2, whereas NFkB is activated post-
translationally. From Ron, D.  Nature Reviews 2007. 
 
 
PERK activation not only promotes global translation attenuation but, 
paradoxically, enhances translation of a few set of mRNAs of which ATF4 is the 
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best studied member. The ATF4 mRNA contains multiple upstream open reading 
frames (uORF) that precede the ATF4 ORF. This molecular organization normally 
suppresses ATF4 protein synthesis when ribosomal assembly is efficient as 
ribosomes initiate translation at the uORF. However, during ER stress when 
ribosomal assembly are impaired, the uORFs are bypassed in favor of the ATF4 
start codon (Harding et al., 2000b), (Harding et al., 2000a). ATF4 is a transcription 
factor and promotes expression of a set of genes that restore ER homeostasis. 
ATF6 governs the third branch of the UPR and is the archetype of a growing family 
of transmembrane ER stress sensors, many of them expressed  in a cell-type or 
tissue specific manner. ATF6 bears a ER luminal stress sensing domain coupled, 
via a transmembrane segment, to a cytosolic B-ZIP transcription factor domain 
(Adachi et al., 2008). In response to ER stress, ATF6 is transported to the Golgi 
where specific proteases cleave the transmebrane and liberate the cytosolic 
portion. The soluble cytosolic domain of ATF6 is a transcription factor that upon  
translocation to the nucleus upregulates transcription of a set of  UPR target genes  
that overlap with those activated by XBP1 and ATF4 (Haze et al., 1999; Nadanaka 
et al., 2006; Yoshida et al., 2000). In this manner ATF6 is thought to protect the 
cell from ER stress (Fig. 5).  
Recently  CREBH, a bZIP-containing transcription factor, has been identified to 
mediate the acute-phase response in liver. CREBH is expressed mainly in 
hepatocytes , and its expression is induced by inflammatory cytokines, such as 
TNF- , interleukin   and interleukin-6. When ER stress occurs, CREBH is 
activated and mediates the acute phase response in the liver. CREBH is activated 
through translocation from the ER to the Golgi apparatus where it is cleaved by 
S1P and S2P.the N-terminal fragment of CREBH  translocates to the nucleus 
where it can induce transcription. However, CREBH does not induce the 
expression of genes involved in the UPR. Instead, it binds to a DNA-sequence 
motif in the promoter region of a subset of acute-phase-response genes, including 
the serum amyloid P component and C-reactive protein (Zhang and Kaufman, 
2008). 
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Fig.5 Signaling by ATF6. ATF6 and CREBH are transmembrane proteins with a 
cytoplasmic portion that, when liberated from its transmembrane tether, can bind to 
DNA and activate genes. In unstressed cells ATF6 and CREBH reside in the ER 
membrane. ATF6 trafficking appears to be hindered by binding to the ER 
chaperone BiP to its luminal domain. ER stress disrupts BiP binding and ATF6 and 
CREBH are delivered to the Golgi apparatus. In the Golgi these proteins are 
subjected to two consecutive cleavage by S1P and S2P proteases which liberates 
the cytosolic  portions of the proteins from the membrane and allows their import 
into the nucleus. ATF6 activates a set of UPR target genes not yet fully 
characterized, whereas CREBH activates the acute-phase response genes that 
encode secreted proteins involved in inflammation. From Ron, D.  Nature Reviews 
2007. 
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1.1.3 Cross talk between the arms of the Unfolded Protein Response     
pathway 
 
Whereas IRE1, ATF6 and PERK activation proceed independently in ER-stressed 
cells, the three arms of the UPR communicate with each other extensively. It has 
been found that the transcriptional effects of the three arms overlap significantly, 
which is achieved in part through mutual positive reinforcement.  
Results from experiments performed with C. elegans indicate that there is a 
functional redundancy between the IRE1-XBP1 arm of the UPR and the ATF6 
branch. This is also inferred from the experiments using  knock out animals  
showing that while mutations on either arms  of the UPR signaling are well 
tolerated, compromising both arms blocks worm development (Shen et al., 2001),  
(Shen et al., 2005). Furthermore, genes expression microarray analysis of 
mammalian cell lines show that  XBP1 is transcriptionally activated by both ATF6 
and PERK signaling (Yoshida et al., 2001), (Calfon et al., 2002) .  
The transcription factor CHOP operates as a downstream component of the ER-
stress, at the convergence of the IRE1, PERK, and ATF6 pathways. CHOP is a 
member of the C/EBP family of bZIP transcription factors that is induced by ER 
stress (Ma et al., 2002). The CHOP promoter contains binding sites for all of the 
major inducers of the UPR, including ATF4, ATF6, and XBP1  (Yamamoto et al., 
2004) and different studies have provided evidence that these transcription factors 
have causative roles in inducing CHOP gene transcription.   
 
1.1.4 Links between the Unfolded Protein Response and cell death 
 
Although the UPR is designed to deal with the multitude of ER stresses in a timely 
and efficient manner in order to enhance cell survival, prolonged stress has severe 
consequences including apoptosis.  
Depending on the particular state of the cells and what type of ER stress is 
encountered, the UPR can dynamically increase the folding capacity of the cells, 
and the ability to degrade misfolded unwanted proteins. However, if subjected to 
continuous stress, such that homeostasis is not regained, cells commit to 
apoptosis. 
Increasing evidence indicates that the UPR regulates both apoptotic and survival 
effectors. The balance between the effectors depends on the nature of the ER 
stress, whether it is tolerable or irresolvable. It remains to be elucidated how the 
cell senses the level of stress and what is the nature of the switch. Up to now no 
trigger for ER stress has been identified that selectively elicits only protective 
response or only apoptosis. Instead ER stress activates all UPR signaling 
pathways, thereby simultaneously producing antagonistic outputs. It has been 
suggested that the duration of individual UPR branch activity may determine the 
cell outcome. 
Moreover to date it is unknown how cells integrate the different pro-apoptotic 
signals to ultimately make a life/death decision. The choice to commit to cell death 
rather than display potentially malformed and malfunctioning protein receptors on 
the cell surface may be the ultimate solution to protect the organism from cells that 
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no longer respond to their environment, and hence may exhibit uncontrolled growth 
or differentiation. 
The ER-proximal sensors PERK and IRE1 are able to activate both cell survival as 
well cell death pathways. While IRE1 leads to activation of the JNK and 
downstream caspases, PERK death-signaling pathway is mediated by the 
transcriptional activation of CHOP (Fig. 6).   
IRE1 exhibits signaling functions beyond its nucleolitic activity.  Recruitment of 
TRAF2 (Tumor necrosis factor receptor 2) allows the activation of the stress 
induced Jun N-terminal kinase (JNK) and the interaction with components of the 
cell death machinery, such as the ER-localized caspase 12 in mice (Urano et al., 
2000), (Nishitoh et al., 2002; Nishitoh et al., 1998) and caspase 4 in human.  The 
IRE1-JNK signaling pathway is also connected to the cell death mechanism by 
activation of the pro-apoptotic BCL-2 family member BIM, while inhibiting the anti-
apoptotic protein BCL-2 (Hetz et al., 2006). 
In addition it has been reported that IRE1 interacts with the BCL-2-associated X-
protein (BAX) and BCL-2 antagonist/killer (BAK) therefore modulating the UPR 
signaling outcomes. 
PERK signaling promotes cell death through specific transcriptional induction of 
the CHOP gene. Upregulated CHOP expression promotes cell death (McCullough 
et al., 2001), whereas CHOP deletion protects against the death of stressed cells 
(Oyadomari et al., 2002; Zinszner et al., 1998). These observations indicate the 
CHOP evolved to link insurmountable levels of ER stress to the cell-death 
machinery. However, alternative explanations for increased survival of ER stress 
CHOP 
-/-
 cells have emerged. It has been found that CHOP activates GADD34, 
reduced levels of GADD34 protein in CHOP
-/-
 cells correlate with sustained 
elevation of phosphorylated eIF2sustained repression of translation, lower levels 
of unfolded ER proteins and, consequently, lower levels of ER stress (Marciniak et 
al., 2004). Therefore, the CHOP-dependent GADD34-mediated negative feedback 
on levels of phosphorylated eIF2 can, in some circumstances, be maladaptive 
because it encourages excessive recovery of the ER load in stressed cells. 
 13 
 
 
 
Fig.6 ER stress and cell death. Cell death by ER stress occurs by a porly 
understood mechanism. Altered Ca handling might be implicated in the 
translocation of the death effectors BAX  and BAK from the ER to the 
mitochondria. In mice caspase 12 activation is implicated in cell death through 
TRAF2. IRE1-mediated activation of JNK contributes to cell death by 
phosphorylating and inactivating the anti-apoptotic regulator BCL2. The formation 
of a complex with the pro-death proteins BAX and BAK may assist in IRE1 
activation. The transcription factor CHOP may repress BCL2 expression. CHOP is 
also engaged in a negative feedback loop that operates in the UPR to promote 
eIF2a dephosphorylation and recovery from protein synthesis. From Ron, D.  
Nature Reviews 2007. 
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1.2 Previous work  
 
Secretory and transmembrane proteins that enter the ER have to fold in this 
compartment in order to reach their ultimate functional state. As polypeptides are 
folded in the ER, sugars are added and disulfide bonds are formed. All of these 
essential processes are helped by ER-resident proteins, such as molecular 
chaperones and protein modifying enzymes. Physiologic stresses, such as 
increased secretory load, change in oxygen availability  or pathological stresses, 
such as the presence of mutated proteins that cannot properly fold in the ER, can 
lead to an imbalance between the demand for protein folding and the capacity of 
the ER for proper folding. When this imbalance is detected a signal is sent to the 
nucleus where numerous appropriate genes are switched on to produce more ER 
and to help protein folding. In this way, the UPR allows the cell to adjust the 
amount of organelle and ER components, according to need. It is one of the many 
homeostatic mechanisms by which cells keep their various constituent parts in 
proper balance.  
In chapters 1.2.1.1; 1.2.1.2 and 1.2.1.3 we  analyzed the folding requirements for 
efficient secretion of coagulation factor VIII (FVIII) a large glycoprotein that is 
deficient in the X chromosome-linked bleeding disorder hemophilia A. As FVIII is 
prone to misfolding in the ER lumen, its expression provides a unique approach to 
study and manipulate the ER stress response that does not rely on 
pharmacological intervention.  
Our next step was to assess whether different cells and tissues may be able to 
modulate different components  of the complex UPR pathway in response to 
specific cellular functions or environmental conditions. Our experimental work used 
as a biological model the plasma cells, the Ig-secreting effectors of the immune 
system, as they represent an ideal model to investigate the cellular dynamics of 
proteosynthetic stress. Moreover, it has been reported that during plasma cell 
differentiation ER-resident proteins are synthesized before Ig accumulation. These 
observations suggest that the activation of certain UPR elements may be driven by 
specific developmental program(s), rather than being solely a consequence of 
cargo accumulation. 
In chapters 1.2.2.1 and 1.2.2.2  we reported that the proteasome capacity 
dramatically decreases along with plasma cell differentiation. In striking correlation 
with impaired proteolysis, polyubiquitinated proteins accumulate, death-inducing 
proteins are stabilized, presumably via competitive inhibition of their degradation, 
and apoptotic sensitivity to proteasome inhibitors ensues, prior to spontaneous 
apoptosis thus attesting to a cause–effect relationship between proteasomal 
overload and death.         
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1.2.1 Posttranslational requirements for Factor VIII folding result in 
the endoplasmic reticulum stress 
 
Factor VIII  (FVIII) is the X-chromosome –linked gene product that is defective in 
the bleeding disorder hemophilia A. FVIII functions in the blood-clotting cascade as 
the cofactor for FIXa proteolitic activation of FX.To date there are no known 
primary or natural established cell lines that express FVIII, thus our knowledge of 
FVIII synthesis and secretion is derived from interpretation of results obtained by 
transfection of mammalian cells with plasmid vectors containing the FVIII cDNA. 
FVIII expression in these systems is two to three orders of magnitude lower than 
that observed with other genes, including the homologous Factor V, using similar 
expression strategies.  
The biosynthesis, folding and secretion of FVIII were studied to elucidate the 
mechanisms responsible for the low level of FVIII expression in transfected 
mammalian cells. At least three mechanisms were identified that limit FVIII 
expression: 1) FVIII mRNA is inefficiently expressed, 2) high levels of von 
Willebrand Factor are required to promote stable accumulation of FVIII, 3) the 
primary translation product is inefficiently folded and transported from the 
endoplasmic reticulum (ER) to the Golgi apparatus. 
The work performed in Kaufman laboratory at HHMI focused mainly in two area of 
research: 
i) Identification of the structural requirements for efficient FVIII protein synthesis, 
assembly and secretion  
ii) Identification of the intracellular factors  that limit FVIII secretion 
i) FVIII is synthesized as a single polypeptide chain of 2351 amino acids from 
which the first 19 residues, corresponding to a hydrophobic signal peptide, are 
removed in the ER.  Internal sequence homologies of the protein indicate a 
triplicated A domains homologous to the A domains of factor V and ceruloplasmin,  
a duplicated C domain and a large B domain that is not homologous to any other 
known structure and that is dispensable for FVIII activity. Several N-linked 
glycosylation sites, are modified in the endoplasmic reticulum (ER). Upon secretion 
from the cells FVIII is further processed by cleavage to yield a heterodimer 
consisting of a 220 kDa amino-terminal heavy chain, associated in a metal ion-
dependent manner with a carboxyl-terminal-derived light chain. 
The evolutionary and structural conservation  between the coagulation factors and 
the blue oxidases suggests a role for copper ion binding in the coagulation factors. 
We have studied the copper ion oxidation state and the ligands that coordinate 
copper ion binding in FVIII by atomic absorption spectroscopy, site-directed 
mutagenesis and expression of FVIII cDNA. The results evidence that a single 
molecule of reduced copper Cu(I) is buried within FVIII and is released and 
oxidized to Cu(II) upon treatment with EDTA. Site-directed mutagenesis and 
functional characterization of the expressed mutated proteins allowed the 
identification of the Cys 310 as the ligand within the type-1 copper binding site. 
ii) During its folding in the ER, FVIII binds to the chaperone BiP and to the lectin 
proteins calnexin and  calreticulin. Binding to BiP correlates with its inefficient 
secretion. Altogether these three ER resident chaperones exert a tight “quality 
control’ on FVIII folding and have a negative effect on the secretion process 
causing ER-stress. In addition FVIII requires ATP for release from BiP and 
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secretion. We demonstrated that FVIII forms transient aggregates immediately 
after its synthesis in the ER. We have studied the properties of this aggregation to 
conclude that aggregate formation increases with the FVIII expression level and is 
reversible. The aggregates do not contain interchain disulfide bonds, although they 
do require ATP for disaggregation.  A hydrophobic region within FVIII, between 
amino acid residues 227-336, was identified that may predispose FVIII to 
aggregation. When this region was replaced by the homologous residues from FV, 
the extent of aggregation was significantly reduced.  
 
1.2.1.1 Identification and Functional Requirement of Cu(I) and Its Ligands 
within Coagulation Factor VIII  
 
ABSTRACT: Coagulation factor VIII (FVIII) is a heterodimer consisting of a light 
chain of 80 kDa (domains A3-C1-C2) in a metal ion-dependent association with a 
220-kDa heavy chain (domains A1-A2-B). The nature of the metal iondependent 
association between the heavy and light chains was investigated using atomic 
absorption spectroscopy, electron paramagnetic resonance spectroscopy (EPR), 
and site-directed mutagenesis and expression of the FVIII cDNA. Whereas copper 
ion was not detected in intact recombinant FVIII, EDTA dissociation of the chains 
yielded an EPR signal consistent with 1 mol of Cu(I)/mol of active protein, 
supporting the hypothesis that a single molecule of reduced copper ion is buried 
within intact FVIII and is released and oxidized upon treatment with EDTA. Cu(I), 
and not Cu(II), was able to reconstitute FVIII activity from dissociated chains, 
demonstrating a requirement for Cu(I) in FVIII function. Three potential copper ion 
binding sites exist within FVIII: one type-2 site and two type-1 sites. The 
importance of these potential copper ion ligands was tested by studying the effect 
of site-directed mutants. Of the two histidines that compose the type-2 binding site, 
the His-19573Ala mutant displayed secretion, light and 
heavy chain assembly, and activity similar to wild-type FVIII, while mutant His-
993Ala was partially defective for secretion and had low levels of heavy and light 
chain association and activity. In contrast, FVIII having the mutation Cys-310 3 Ser 
within the type-1 copper binding site in the A1 domain was inactive and partially 
defective for secretion from the cell, and the heavy and light chains of the secreted 
protein were not associated. Mutant Cys-2000 3 Ser within the A3 domain 
displayed secretion, assembly, and activity similar to that for wildtype FVIII. These 
results support the hypothesis that Cu(I) is buried within the type-1 copper binding 
site within the A1 domain and is required for FVIII chain association and activity. 
 
 
1.2.1.2 ATP-Dependent Dissociation of Non-Disulfide-Linked Aggregates of 
Coagulation Factor VIII Is a Rate-Limiting Step for Secretion 
 
ABSTRACT: Deficiency in coagulation factor VIII leads to the bleeding disorder 
hemophilia A. Previous studies demonstrated that factor VIII secretion is limited 
due to an ATP-requiring step early in the secretory pathway. In this report, we 
identified that this ATP-dependent rate-limiting step involves the dissociation of 
non-disulfide-linked aggregates within the endoplasmic reticulum (ER). In contrast 
to the numerous examples of interchain disulfide-linked aggregates, factor VIII is 
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the first protein characterized to form non-disulfide-linked high molecular weight 
aggregates within the ER. Approximately a third of newly synthesized factor VIII 
was detected in high molecular weight aggregates. These aggregates disappeared 
over time as functional factor VIII appeared in the medium. The aggregated 
complexes did not require proteasomal degradation for clearance. Aggregate 
formation was enhanced by ATP depletion, and upon restoration of metabolic 
energy, these aggregates were dissociated and secreted. With the coexpression of 
von Willebrand factor (vWF), a small portion of vWF coaggregated with factor VIII. 
However, vWF dissociated from the aggregates more rapidly than factor VIII, 
supporting that these aggregates are dynamic. An increase in the factor VIII 
expression level elicited a corresponding increase in the fraction of factor VIII that 
was aggregated. In addition, a 110 amino acid sequence containing a hydrophobic 
â-sheet within factor VIII was identified that may predispose factor VIII to 
aggregation. These data show that formation and ATP-dependent dissolution of 
nondisulfide-linked factor VIII aggregates is a dynamic, rate-limiting step during the 
folding process in the early secretory pathway. In summary, we have identified an 
unprecedented requirement for protein transport out of the ER that involves an 
ATP-dependent dissociation of non-disulfide-linked aggregates within the ER. 
 
1.2.1.3. Biosynthesis, assembly and secretion of coagulation FVIII 
 
Factor VIII is a large complex glycoprotein that is deficient in hemophilia A. It has a 
domain organization consisting of A1-A2-B-A3-C1-C2  where the B domain is a 
heavily glycosylated region that is dispensable for procoagulant activity. Factor VIII 
expression is a 10- to 20 fold lower than the homologous factor V. Factor VIII 
expression is limited due to a low level of steady-state messenger RNA in the 
cytoplasm and inefficient transport of the primary translation product from the 
endoplasmic reticulum to the Golgi apparatus. Within the secretory pathway, factor 
VIII is processed to a heterodimer of a heavy chain (domains A1-A2-B) in a metal 
ion association with the light chain ( domains A3-C1-C2). Upon secretion from the 
cell, von Willebrand factor binds the light chain of factor VIII and stabilizes the 
factor, preventing degradation. Protein folding within the mammalian secretory 
pathway is facilitated by molecular chaperones. Within the endoplasmic reticulum, 
factor VIII exhibits stable interaction with protein chaperones identified as the 
immunoglobulin-binding protein (BiP), calnexin and calreticulin. BiP is a peptide 
dependent ATPase that interacts with exposed hydrophobic surfaces on unfolded 
proteins or unassembled protein subunits. A potential BiP binding site within factor 
VIII has been identified. Mutation of a single amino acid residue in the potential BiP 
binding site increased the secretion efficiency of factor VIII by threefold. 
Interestingly, the proposed BiP binding site is adjacent to a type-1 copper binding 
site within the A1 domain that is required for interaction between the factor VIII A1 
domain and the A3 domain. We propose that Cu(I) binds the type-1 copper ion-
binding site in the A1 domain and provides the essential requirement for a stable 
interaction between the heavy and light chains. Calnexin and Calreticulin are 
transmembrane and luminal proteins, respectively, localized to the endoplasmid 
reticulum, which associate  transiently  with many soluble and membrane 
glycoproteins during folding and subunit assembly. The calnexin and calreticulin 
interaction with factor VIII occurs primarily through amino-terminal linked 
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oligosaccharides within   the heavily glycosylated factor VIII B domain and this 
interaction appears to be required for factor VIII secretion. The findings suggest 
that factor VIII cycles through interactions with BiP, calnexin and calreticulin. 
Although the interaction with BiP does not appear to be required for factor VIII 
secretion, data suggest that the calnexin and/or calreticulin interaction is required 
for secretion. The observations suggest a unique requirement for carbohydrate 
processing and calnexin/calreticulin interaction that may limit the productive 
secretion of factor VIII and have implications for approaches towards somatic cell 
gene therapy for hemophilia A. 
 
1.2.1.4 Concluding remarks 
 
The studies performed in Kaufman’ lab used an unique powerful protein model 
system to elucidate the functional roles of carbohydrate processing, chaperones 
interaction and  ER-stress  that  limit the productive secretion of FVIII and may 
have implications for approaches towards somatic cell gene therapy for 
hemophilia. Most importantly,  these  studies  highlighted how inefficient FVIII 
secretion correlates with Interaction with the protein chaperone identified as the 
immunoglobulin binding protein (BiP), also called glucose-regulated protein of 78 
kDa (GRP78) within the lumen of the ER. This chaperone is expressed in all cell 
types and is a member of the heat-shock protein family whose expression is 
induced at the transcriptional level by the presence of unfolded proteins or 
unassembled protein subunits within the ER.  
BiP interaction with unfolded proteins or protein folding intermediates is a common 
feature of many secretory and transmembrane proteins that could not negotiate the 
stringent “quality control” system within the ER.  This process involves a variety of 
mechanisms that collectively ensure that only correctly folded, assembled and 
modified proteins are transported along the secretory pathway. In contrast, non-
native proteins are retained and eventually targeted for degradation. 
 
1.2.2 The physiological role of the unfolded protein response: shaping 
B lymphocytes differentiation and limiting plasma cells lifespan  
 
The occurrence of ER stress is observed in many physiological processes, 
especially in highly secretory cells such as plasma B lymphocytes, salivary gland 
and pancreatic  cells. The high demand for efficient protein folding and secretion 
processes in these cells constitutes a constant source of stress initiated by the 
presence of large amount of misfolded proteins that are normally generated during 
protein maturation. These folding sub-products are eliminated through ER-
associated degradation (ERAD), where misfolded proteins translocate to the 
cytosol and are degraded by the proteasome. 
To explore the ER stress in cells adaptation and death in physiological process we 
used two cell models as prototypes of professional secretory cells: i) antibody-
secreting plasma cells derived  from mice spleen and ii)  B cell lymphoma  that can 
be induced to differentiate in vitro. Plasma cells are the end-stage effectors of the 
humoral immune response, producing large amount of secretory immunoglobulins 
(IgM), being capable to release thousands Ig molecules per seconds. To achieve 
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these standards they expand the organelles devoted to protein synthesis, transport 
and secretion, and in particular the endoplasmic reticulum (ER) where Igs are 
synthesized, folded and assembled. How is this metamorphosis coordinated? 
Proteomic analysis of B cells induced to differentiate with lipopolysaccharide (LPS) 
shows  that the LPS-stimulated B cells activate a developmental program that 
induces the stepwise synthesis of different class of proteins so as to increase the 
secretory capacity.  After LPS induction ER-resident proteins increase over the 
entire time whereas IgM subunits increase significantly only after 2-3 days of LPS 
treatment, to become the dominant molecular species synthesized in the last days 
of differentiation. 
LPS-stimulated B cells begin to die after day 3 or 4, concomitantly with massive 
IgM secretion and accumulation of spliced XBP1. This finding, together with 
previous observation that XBP1 is essential for plasma cell development, 
suggested that exuberant Ig synthesis causes stress, induces ER biogenesis and 
eventually apoptosis via UPR-related pathways.  
While confirming a correlation between massive Ig production and plasma cell 
death, our finding reveal that the proteasomal capacity decreases during plasma 
cell differentiation, despite the higher demand imposed by the high rates of 
proteins production. Thus an unfavorable proteasomal load versus capacity can 
predispose cells to apoptosis. This finding is further supported from the fact that 
proteasome inhibitors have been proved particularly effective in the therapy of 
multiple myeloma by inducing apoptosis of malignant cells. 
 
1.2.2.1 The making of a professional secretory cell: architectural and 
functional changes in the ER during B Lymphocyte plasma cell 
differentiation 
 
ABSTRACT: B lymphocytes are small cells that express antigen receptors and 
secrete little if any IgM. Upon encounter with antigen, they differentiate into short-
lived plasma cells, which secrete large amounts of polymeric IgM. Plasma cell 
differentiation entails a massive development of the endoplasmic reticulum to 
sustain high levels of Ig production. Recent findings suggest a role for the unfolded 
protein response in orchestrating the architectural and functional changes during 
terminal plasma cell differentiation. 
 
1.2.2.2. Progressively impaired proteasomal capacity during terminal plasma 
cell differentiation 
 
ABSTACT: After few days of intense immunoglobulin (Ig) secretion, most plasma 
cells undergo apoptosis, thus ending the humoral immune response. We asked 
whether intrinsic factors link plasma cell lifespan to Ig secretion. Here we show that 
in the late phases of plasmacytic differentiation, when antibody production 
becomes maximal, proteasomal activity decreases. The excessive load for the 
reduced proteolytic capacity correlates with accumulation of polyubiquitinated 
proteins, stabilization of endogenous proteasomal substrates (including Xbp1s, 
and Bax), onset of apoptosis, and sensitization to proteasome inhibitors (PI). 
These events can be reproduced by expressing Ig-l chain in nonlymphoid cells. 
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Our results suggest that a developmental program links plasma cell death to 
protein production, and help explaining the peculiar sensitivity of normal and 
malignant plasma cells to PI. 
 
1.2.2.3 Concluding remarks 
 
Physiologically the UPR is thought to monitor the demand placed on the ER folding 
machinery and allow cells to promptly adapt to novel developmental requests. 
Therefore the remarkable increase in Ig production that accompanies B to plasma 
cell differentiation could drive the expansion of the ER via the UPR. Of note, XBP1
-
/- 
mice lacks plasma cells and serum Igs, despite having normal numbers of B 
lymphocytes. It is thus clear that XBP1 is essential for terminal B cell 
differentiation. 
The extensive similarity between the luminal domains of IRE and PERK  create a 
paradoxical situation for plasma cells. On one hand, these cells require XBP1s and 
hence an active IRE1 pathway. On the other hand PERK mediated translational 
attenuation would be detrimental for the plasma cells mission, that is, massive 
antibody production. Recent experiments shows that B lymphocytes are capable of 
activating all three branches of the UPR pathway if challenged with 
pharmacological stressors like tunicamycin or thapsigargin. However, in response 
to plasma cells differentiation signals, a modified UPR is initiated.  IRE1 is 
activated early, leading to XBP1 splicing. Perk shows sign of partial activation with 
kinetic similar to IRE1, but this is not sufficient to phosphorilate the eIF2 or to 
induce its downstream targets. These events occur prior to the upregulation of Ig 
transcripts or proteins, arguing that this is not the signal for their activation. ATF6 
appears to be activated considerably later and could be activated by increasing 
processing of Ig proteins (Ma et al., 2010). 
Our results show that the proteasomal capacity decreases in differentiating plasma 
cells, despite the higher demand imposed by high rates of Igs production. The 
stabilization of two pro apoptotic proteasome substrates known to control plasma 
cells lifespan as Bax and Bim may, at least in part, explain their relative increase 
with respect with Bcl2, until the death threshold is reached. In this scenario plasma 
cell death would be linked to Ig production, thus contributing to end humoral 
response. 
The finding that an unfavorable proteasomal load/capacity ratio can predispose 
cells to apoptosis has important implications for the physiology of the immune 
system and for Ig-secreting tumors. In fact, in myeloma the reliance on the UPR is 
not diminished by neoplastic transformation and it may provide a method for 
selectively targeting myeloma cells, and potentially other cancers, which are known 
to be secretory and therefore dependent on the UPR. 
 
 
 
 
 
 
 
 21 
 
1. 3  Cell stress and hypoxia 
 
 1.3.1 The hypoxia signaling pathway 
 
Access to oxygen is crucial for most organisms, even small fluctuations in oxygen 
levels pose a threat and molecular mechanisms have evolved in multicellular 
organisms to sense and adapt to changes in oxygen levels. When oxygen 
becomes limiting, cells respond by resetting their cellular metabolism to a low 
oxygen consumption mode and minimizing the influence of free oxygen radicals. 
Cells decrease the oxidative phosphorylation and rely on glycolysis as the primary 
means of ATP production by upregulating the expression of genes that encode 
glycolitic enzymes and glucose transporters.  At the tissue level the adaptation to 
low oxygen regulates several physiological parameters to increase the oxygen 
supply. Therefore, hypoxia enhances vascularization and de novo angiogenesis by 
upregulation of the angiogenic factor vascular endothelial factor A (VEGFA) and 
improves the oxygen carrying capacity of blood by enhancing the expression of 
erythropoietin (EPO). 
In mammalian cells the hypoxia-induced transcription factor (HIF)1 is a master 
regulator of O2 homeostasis. HIF-target genes enable cells to survive oxygen 
deprivation by providing oxygen-independent means of ATP production and/or by 
inhibiting hypoxia-induced apoptosis.  
HIFs  facilitate both oxygen delivery and adaptation to oxygen deprivation by 
regulating the expression of genes that are involved in many cellular processes, 
including glucose uptake  and metabolism, angiogenesis, erythropoiesis, cell 
proliferation, and apoptosis. HIF proteins are member of the PAS (PER-ARNT 
arylhydrocarbon receptor nuclear translocator-SIM) family of basic transcription 
factors that bind to DNA as heterodimers composed of an oxygen sensitive alpha 
subunit and a constitutively expressed beta subunit. To date three HIFs (HIF 1, 2, 
3) have been identified, that regulate transcriptional programs in response to low 
oxygen levels. While HIF1 is ubiquitously expressed, HIF2 is only expressed in 
endothelial cells and in the kidney, heart, lungs and small intestine.  HIF3 is 
expressed in the thymus, cerebellar Purkinje cells and the corneal epithelium of the 
eye (Gordan and Simon, 2007).  
HIF1 is a heterodimeric protein that is composed of a constitutively expressed 
HIF1subunit and an O2-regulated HIF1 subunit. HIF1 is subjected to O2-
dependent hydroxylation on proline residue 402 and/ or 564 by prolyl hydroxylase 
domain proteins (PHDs) and this modification creates an interface for interaction 
with the von Hippel-Lindau tumor suppressor protein (VHL) (Fig.8), which recruits 
an E3 ubiquitin-protein ligase that catalyzes polyubiquitination of HIF1, thereby 
targeting it for proteasomal degradation (Brahimi-Horn et al., 2007; Lum et al., 
2007). Hence, HIF activity is regulated by a cycle of synthesis and oxygen-
dependent degradation under normoxic conditions. Under hypoxic conditions, 
decreased molecular oxygen diminishes the activity of PHDs and these are further 
inhibited by reactive oxygen species (ROS) released from inefficiently respiring 
mitochondria (Brunelle et al., 2005; Guzy et al., 2005; Kaelin, 2005; Lu et al., 
2005). The ROS oxidize and inactivate the ferrous ion within the active sites of the 
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PDHs. This renders the PDHs incapable of modifying the HIF1 subunit, resulting 
in the stabilization of HIFs. The stabilized HIF1, dimerizes with HIF1 binds to a 
core DNA binding sequence 5’-RCGTG-3’ (R, purine A or G) in target genes, 
recruits the co-activators CREB and p300, and activates transcription (Jiang et al., 
1996) (Mahon et al., 2001)(Fig.8).   HIF1 heterodimers transactivate genes 
involved in pH regulation, glucose transport, glycolysis and vasculogenesis, 
allowing for cellular adaptation to hypoxia (Gordan and Simon, 2007; Semenza, 
2003). HIF2 is a protein with extensive sequence homology to HIF1 that is also 
regulated by proline and asparagines hydroxylation, dimerizes with HIF1 and 
activates transcription of a group of target genes that overlap with, but is distinct 
from, those regulated by HIF1(Jain et al., 1998),(Tian et al., 1997)(Wiesener et 
al., 2003)Fig.7. HIF3 is an inhibitor of HIF1 that may be involved in feedback 
regulation because its expression is transcriptionally regulated by HIF1(Gu et al., 
1998), (Makino et al., 2001). 
 
Figure 7. HIF regulation by proline hydroxylation. (A) In normoxia, HIF1 is 
hydroxylated by proline hydroxylases (PHD1,2,3) in the presence of oxygen, Fe
2+
, 
2-oxoglutarate (2-OG) and ascorbate. Hydroxylated HIF1(OH) is recognized by 
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the product of the von Hippel-Lindau tumor suppressor gene pVHL, which, 
together with a multisubunit ubiquitin ligase complex, tags HIF1 with ubiquitin. 
This allows recognition by the proteasome and subsequent degradation. 
Acetylation of HIF1(OAc) also promotes pVHL binding. (B) In response to 
hypoxia, proline hydroxylation is inhibited, VHL is not longer able to bind and target 
HIF1 for proteasomal degradation, which leads to HIF1 accumulation and 
translocation to the nucleus. HIF1 dimerizes with HIF1, binds to the hypoxia 
response elements (HREs) within the promoters of target genes and recruits 
transcriptional coactivators such as p300/CBP for full transcriptional activity. A 
range of cellular functions are regulated by the target genes. From Stewart et al. 
BJUI, 2009. 
 
However, HIF-1 activation alone may not account for the full repertoire of 
changes that occur when O2 decreases and other hypoxia-dependent paths are 
activated independently of HIF-1. 
More recently, two other pathways that independently influence gene expression 
and processes of importance for cell growth have proved to be O2-sensitive. The 
first occurs through regulation of an important integrator of metabolic signals, the 
kinase mammalian target of rapamacyn (mTOR, also known as FRAP1) and its 
downstream effectors that orchestrate the initiation of protein synthesis, autophagy 
and apoptosis sensitivity (Arsham et al., 2003). The second occurs through 
activation of the UPR. Hypoxia has been demonstrated to influence several 
components of both of these pathways, each of which is uniquely dependent upon 
the severity and/or duration of the hypoxic stress. Consequently, the cellular 
response to hypoxia may demonstrate a significant heterogeneity (Fig. 8). 
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Figure 8. Cellular oxygen-sensing pathways. Three main O2-sensing pathways 
promote hypoxia tolerance by regulating the mRNAs transcription and translation.  
First hypoxia stabilizes the HIF1 facilitating its heterodimerization with HIF1 and 
transcriptional activation of downstream genes. Second, hypoxia triggers the UPR 
by activation of the ER-stress sensors PERK, IRE1 and most probably ATF6. IRE1 
and ATF6 both induce a transcriptional response, while PERK causes inhibition of 
translation. Third, the activity of mTORC1, a complex containing the mammalian 
target of rapamycin (mTOR) kinase, which integrates and transmits positive and 
negative growth signals to the translational machinery, is inhibited by hypoxia. 
Changes in mRNA translation can be highly gene-specific and thus can also 
significantly contribute to differential protein expression during hypoxia. Together 
these three pathways influence the phenotype of hypoxic cells by altering 
metabolism, angiogenesis, autophagy and ER homeostasis. From Wouters et al. 
Nature Reviews Cancer, 2008. 
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1.3.2 Unfolded Protein Response activation during hypoxic stress 
 
Hypoxic activation of ER stress sensors strongly suggests that the lack of O2 
perturbs ER homeostasis. However, the direct requirement for O2 in ER function 
remains to be fully clarified. The immediate phosphorylation of eIF2 upon anoxic 
exposure suggests a direct role for O2 in ER protein maturation, involving several 
steps of oligosaccharide modifications, disulphide bonds formation, isomerization, 
quality control and export. Any of these processes may harbor requirements for O2. 
In vitro, O2 can supply the oxidative potential to drive disulphide bonds formation of 
a client protein by FAD, ER-oxidase 1 (ERO1) and Protein Disulphil  Isomerase 
(PDI) (Tu and Weissman, 2002). It remains to be established whether O2 is a 
crucial electron acceptor in the ER of mammalian cells in vivo, and whether this 
can account for the limited ER function during hypoxia 
Little is known  about the hypoxia associated changes involving PERK, IRE1 and 
ATF6 that affect the sensitivity to UPR activation. However, the cellular 
consequences of their activation are mediated by four distinct pathways that 
collectively act to alleviate ER stress and diminish its toxic effects. Each of these 
effectors pathways can influence the phenotype of hypoxic cells in diverse ways. 
The effector pathways include two “preventative” pathways ,that mediate inhibition 
of mRNA translation and induction of protein maturation machinery. Together 
these pathways function to prevent further accumulation of unfolded protein in the 
ER (Koritzinsky et al., 2006). At the same time UPR dependent processes 
stimulate ER-associated degradation (ERAD) and autophagy to remove potentially 
toxic misfolded proteins or protein aggregates that may have already accumulated 
(Fig 9). 
Regulation of gene-specific mRNA translation. Inhibition of overall protein 
synthesis has long been known to be a hallmark of hypoxia. Part of this inhibition is 
mediated through regulation of the eukaryotic  Initiation factor 4 (EIF4) through 
mTOR-influenced pathway. However, the majority of this effect during acute 
exposures to severe hypoxia is due to PERK-dependent phosphorylation of eIF2 
(Koritzinsky et al., 2006), (Koritzinsky et al., 2007; Koumenis et al., 2002). As is the 
case for mTOR, inhibition of translation through PERK-eIF2 is expected to affect 
both energy homeostasis and specific gene expression. The transcript best 
characterized in this respect is ATF4, the 5’ UTR of which contains two conserved 
upstream open reading frames (uORFs) that prevent efficient translation under 
normal conditions. Reduction of the availability of non-phosphorylated eIF2 
reduces initiation at the second uORF and increases the chance that initiation 
occurs at the bona fide start codon (Lu et al., 2004; Vattem and Wek, 2004). 
Consequently, ATF4 is induced during acute hypoxia in a PERK and eIF2-
phosphorylation-dependent manner (Koritzinsky et al., 2006), (Blais et al., 2004) . 
ATF4 is an important transcription factor and has been shown to be overexpressed 
in cancer primarily in hypoxic, perinecrotic regions of human tumors (Ameri et al., 
2004). Selective synthesis of ATF4 during hypoxia  also appears to be required for 
maintaining hypoxia tolerance  (Bi et al., 2005). Several other transcripts of 
relevance to hypoxia are also selectively translated in a PERK-dependent manner 
including VCIP (VEGF and type 1 collagen-inducible protein) and matrix 
metalloproteinase 13 (MMP13). These effects may explain the defects in 
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angiogenesis that contribute to the poor growth of PERK-deficient tumors (Blais et 
al., 2006). 
The transient inhibition of mRNA translation can also liberate the translational 
machinery (eukaryotic initiation factors, ribosomes) from pre-existing translation 
competent transcripts, such that newly made mRNAs may be able to more 
effectively compete for the translational machinery. This shift in translation has 
been referred to as “translational reprogramming, (Ron and Walter, 2007) and may 
allow for a bias in the synthesis of hypoxia-inducible mRNAs.  
Regulation of protein maturation machinery. Many proteins involved in ER-
localized protein folding and maturation have been reported to be upregulated 
during hypoxic conditions. These includes chaperones such as BiP and GRP94 
(Murphy et al., 1991), (Roll et al., 1991), (Wilson and Sutherland, 1989) as well as 
oxidoreductases such as ERO1L  (Romero-Ramirez et al., 2004), (Gess et al., 
2003), and PDI (Tanaka et al., 2000). Although their induction is predicted to 
improve ER function during hypoxia and potentially mitigate the toxicity associated 
with accumulation of  protein aggregates, this has not yet been formally shown. 
UPR-dependent upregulation of the protein maturation machinery in the ER might 
also contribute to increased secretion of angiogenic factors. Blockade of the UPR 
through expression of a dominant-negative IRE1 has been shown to reduce 
VEGFA secretion and result in smaller tumors with reduced vascular density. 
Similarly, knockdown of ERO1L decreased the ratio of extracellular VEGFA protein 
to intracellular mRNA levels, at least under normoxic conditions (May et al., 2005). 
Regulation of ER-associated degradation. There is a strict quality control of protein 
folding in the ER, which is applied before the proteins exit to the Golgi. If the 
battery of maturation proteins fails to produce a bona fide folded protein, the 
aberrant protein can be targeted for ERAD through mannose trimming of N-linked 
glycans. ERAD is an important detoxification mechanism that prevents protein 
aggregation and cytotoxycity. The importance of ERAD in mediating hypoxia 
tolerance has yet to be investigated, but several proteins involved in ERAD are 
induced by hypoxia. These include HERP, suggesting a link between client 
proteins and the proteasome, SEC61A1 (translocon subunit) (Romero-Ramirez et 
al., 2004) and synoviolin (a ubiquitin ligase) (Qi et al., 2004) and Derlin 3 (our 
results). 
Regulation of autophagy. Growing evidence suggests that autophagy is also 
influenced by the UPR in response to ER stress. In some cases autophagy 
appears to be mediated by PERK, whereas in others it occurs downstream of 
IRE1. For example, aggregation of polyglutamine polypeptides, associated with 
Huntington disease, induces UPR and autophagic vesicles formation through 
PERK (Kouroku et al., 2007), whereas tunicamycin and tapsigargin require IRE1 
(Ogata et al., 2006). The importance of UPR-dependent autophagy mediated by 
PERK or IRE1 in response to hypoxia is currently being investigated by many 
laboratories. 
Regulation of apoptosis and survival. In addition to these four main effectors 
pathways that serves as a tolerance mechanisms, prolonged ER stress becomes 
toxic, and the UPR can  promote apoptosis. The pro-apoptotic family members 
BAX and Bcl2 homologous antagonist/killer (BAK) associate with activated IRE1 
and are required for signaling the transcriptional UPR response through XBP1 
activation (Hetz et al., 2006). Interestingly, the transcriptional regulation of C/EBP 
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homologous protein CHOP, which is induced downstream of both PERK and IRE1, 
confers increased apoptotic sensitivity to at least some forms of ER stress 
(Zinszner et al., 1998). This may occur through the transcriptional regulation of 
CHOP-dependent targets such as ERO1L and GADD34 (Marciniak et al., 2004). 
As GADD34 expression restores protein synthesis by causing eIF2 
dephosphorylation, it therefore increases the client load of proteins that must be 
properly folded within the ER. In the continued presence of agents that disrupt 
protein maturation this can increase their toxicity (Marciniak et al., 2004). Induction 
of ERO1L during ER stress could potentially catalyze disulphide bond in the ER, 
and by doing so, stabilize toxic unfolded protein aggregates.  
 
1.3.3 Hypoxia and UPR signaling in tumors 
 
Tumor hypoxia was first described in the 1950 by radiation oncologists as a 
frequent cause of failure to radiotherapy in solid tumor (Warburg, 1956). Today, it 
is evident that tumor hypoxia and the critical mediators HIFs, regulate multiple 
steps of tumorigenesis, including tumor formation, progression, and response to 
therapy. 
Human cancers contain areas of necrosis in which cancer cells have died due to 
inadeguate oxygenation (Vaupel and Mayer, 2007). Cells closest to a perfused 
blood vessel are exposed to relatively high O2 concentrations, which decline as 
distance from the vessel increases. Although such gradients exist in normal 
tissues, in cancer the gradients are much steeper (Iliopoulos et al., 1996), and O2 
concentrations drop to near zero in areas of necrosis. In addition to physical 
gradients, temporal fluctuations in oxygenation also commonly occur within tumors. 
Immunohistochemical analysis of cancer biopsies revealed increased levels of 
HIF1  and/or HIF2  proteins in the majority of primary human cancers and their 
metastases (Talks et al., 2000). Intratumoral hypoxia is a major mechanism 
underlying the increased levels of HIF1 and HIF2 in cancer and stromal cells. 
Other inducers of HIF1 in the tumor microenvironment include reactive oxygen 
and nitrogen species  (Brunelle et al., 2005),(Kaelin, 2005), which also inhibit 
proteasomal degradation of HIF1. Moreover, the activation of the 
phosphatidylinositol-3-kinase and MAP kinase pathways increases HIF1 
synthesis (Mazure et al., 1997), primarily through the action of mTOR (Majumder 
et al., 2004). 
HIF1 and HIF2 protein levels can also be increased in cancer cells due to loss 
of function of many different tumor suppressors, which results in either increased 
HIF1 synthesis or decreased HIF1 degradation (Maxwell et al., 1999) (Iliopoulos 
et al., 1996; Zelzer et al., 1998), (Zundel et al., 2000). Taken together these 
observations provide evidence that HIF1 activation promotes oncogenesis and/or 
cancer progression 
To date the link between hypoxia and UPR has been studied mainly in the contest 
of cancer cells. Tumor cells have  important interactions with the cellular context in 
which they are found including dependence on fundamental limiting factors such 
as lack of nutrient, oxygen and acidosis. These deficiencies can be partially 
overcome if the tumor is able to establish a blood supply via secretion of pro-
angiogenic factors. In addition, hypoxia and nutrient deprivation inhibit  N-linked 
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glycosylation of proteins, leading to inaccurate protein folding. Thus an important 
adaptive response for the tumor cell is the ability to overcome such limitations. 
Overexpression  of ER-resident chaperones Grp78 and Grp94 has been reported 
in several breast cancer cell lines (Gazit et al., 1999), overexpression of Grp78 has 
also been reported in colon cancer and gastric adenocarcinoma cell lines (Ramsay 
et al., 2005), (Song et al., 2001). Ex-vivo human tissues and animal models have 
reported an increase in Grp78 expression in malignant breast and colon cancer 
and a generalized activation of the UPR in hepatocellular carcinoma, gastric and 
oesophageal adenocarcinoma (Fernandez et al., 2000), (Shuda et al., 2003), 
(Chen et al., 2002) 
It is known that activation of the PERK pathway can be important in mediating 
these effects.   As discussed above, PERK  activity leads to phosphorylation of the 
translation initiation factor eIF2 and suppression of protein synthesis from the 
vast majority of the mRNA present in the cells. Cells bearing genetic mutations that 
disrupt the function of PERK, or its downstream effectors eIF2 and ATF4, all 
show impaired survival and proliferation when challenged with low oxygen levels 
(Bi et al., 2005; Koumenis, 2006; Koumenis et al., 2002). These studies provide 
genetic evidence that PERK signaling can promote cell survival during hypoxia 
(Koumenis and Wouters, 2006). 
Several studies have  linked PERK signaling with enhanced tumor growth and 
survival under hypoxic conditions.  Moreover, it has been reported impaired 
vasculogenesis and cancer cells proliferation in mice models were PERK signaling 
was genetically ablated. These studies suggest a model by which tumor cells 
manipulate PERK signaling to enhance viability by reducing translational activity, 
thereby reducing the metabolic demand, and promote tumor growth by increasing 
the production of angiogenic factors in response to low oxygen levels (Malhotra 
and Kaufman, 2007).   
PERK is also involved in apoptosis induced by tumorigenesis through activation of 
CHOP. Increased CHOP levels have been reported within solid tumors, indicating 
that PERK signaling may be promoting apoptosis in these regions. However it is 
still unclear how cells balance the beneficial versus cytotoxic outputs derived from 
PERK signaling; in fact the attenuation of translation imposed by PERK, while 
providing protective benefits, would ultimately be detrimental if protein synthesis 
fell below levels necessary to sustain cellular functions (Koumenis, 2006). 
However area of central necrosis are often observed within rapidly growing solid 
tumors and it has been hypothesized they could represent  gross manifestations of 
dynamic switching between the protective and toxic properties of PERK signaling. 
XBP1 overexpression has been  observed in colorectal carcinomas, adenomas 
and breast carcinoma. Functional studies of IRE1/XBP1 pathway could 
demonstrate its direct involvement in solid tumor growth. Cancer cells containing a 
homozygous deletion mutation of XBP1 gene showed impaired survival under 
hypoxia (Romero-Ramirez et al., 2004). The XBP1
-/-
 cells also failed to form tumors 
in animals. Experiments using a human tumor xenograft expressing an XBP1s-
luciferase fusion protein, demonstrated the expression of spliced active XBP1s in 
all tumors including small ones, suggesting that the ER stress persists throughout 
tumor growth (Spiotto et al., 2010). Activation of the third ER stressor ATF6 by 
hypoxia has not been demonstrated but is probable, based on the information that 
many of its transcriptional targets are induced under hypoxic conditions. Taken 
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together these results demonstrate an important role for the UPR in determining 
hypoxia tolerance and tumor growth. 
 
 
 
Figure 9. Hypoxia activates the UPR. The ER stress sensors are activated 
during ER stress through loss of binding to BiP and/ or direct interaction with 
misfolded proteins and aggregates. PERK activation results in inhibition of global 
mRNA translation. A transcriptional response also occurs through activation of the 
transcripton factors ATF4, XBP1 and ATF6. Hypoxic activation of ATF6 has not 
been directly demonstrated, but is probably based on hypoxic induction of ATF6-
dependent genes such as BiP and GRP94 and Derlin3 (our observations). ATF4, 
XBP1 and ATF6, induce an overlapping set of proteins that increase the capacity 
for ER-localized proteins maturation and ER-associated degradation (ERAD). The 
molecular pathways that lead to ER-stress induced autophagy remain unknown, 
but are dependent on PERK and/or IRE1. The basis for how hypoxia causes ER-
stress and activation of the UPR is not yet fully understood. From Wouters et al. 
Nature Reviews Cancer 2008. 
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Since enhanced  survival of tumor cells under hypoxic conditions mediated by 
PERK and IRE1/XBP1 have been observed in established tumors, that raises the 
intriguing questions regarding whether such cells have a selective prosurvival 
advantage that contribute to the process of advanced carcinogenesis. No data are 
available about the role of the UPR on cancer initiation. Moreover many 
experimental data, with simulated hypoxic conditions, have been documented in 
cultured cells  grown in anoxia.  
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2.SCOPE OF THE THESIS 
 
2.1 Rationale 
 
The protein components of eukaryotic cells face acute and chronic challenges to 
normal folding, refolding and function owing to a constant barrage of physical, 
metabolic and environmental stresses. The endoplasmic reticulum (ER) responds 
to the accumulation of unfolded proteins in its lumen (ER stress) by activating 
intracellular signal transduction pathways, cumulatively called the unfolded protein 
response (UPR). The UPR activation triggers an extensive transcriptional and 
translational response, which adjusts the ER protein folding capacity according to 
needs. As such, the UPR constitutes  one of the signaling pathways that  regulates  
the capacity and composition of the ER according to the folding capacity.   
The experimental work described in this thesis aims at delineating the  ER 
homeostasis by analyzing the heterogeneity of stresses and the fine tuning of the 
UPR signaling in different cellular conditions. My initial works studied the changes 
of the ER homeostasis when cells overexpress secretory proteins and during 
plasma cell differentiation (Chapter 1.2). Recent studies have indicated that the 
cells suffering from insufficient blood supply experience stress. The ER needs 
energy and oxygen (O2) for the folding process, thus nutrient deprivation and 
hypoxia, caused by insufficient oxygen, lead to inefficient protein folding and ER 
stress.   Hypoxia alters the behavior of the cells through different O2 sensitive 
pathways, the best understood  is the one mediated by the hypoxia inducible factor 
family of transcription factors (HIFs).  Recent in vitro studies  have shown that   the  
hypoxic stress  triggers the UPR. However, in vivo and in vitro situations are 
indeed likely to diverge substantially with respect to parameters such as metabolic 
activity, O2 utilization and cell division rates, features that are predicted to vary the 
cell sensitivity to ER stress.  Thus, despite a recognized role for hypoxia on UPR, 
few data exist on the effects of hypoxia in various organs in vivo. 
 
2.2 Aims  
 
Our study includes three aims: 
- First  we will test if the hypoxic stress  in vivo acts as a modifier that  affects 
the activation of specific branches of the UPR in different tissues. 
- Second, to get a better insight into the role of the UPR during low oxygen 
availability in tissues, we test whether the UPR activation depends from the 
severity of the hypoxic stress. 
- Third we aim at delineating  signaling circuits that control the capacity and 
composition of the proteostasis network  through transcriptional and post 
transcriptional mechanisms to balance the ER homeostasis 
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2.3 Strategy 
 
To test the UPR dependence on stress severity, we expose mice to two levels of 
O2 reduction for 5 h, a time frame that allows induction of mRNA transcripts before 
the setting of adaptive mechanisms. We give priority to liver and myocardium 
tissues because they are homogeneous tissues and widely differ in terms of O2 
availability and requirement. Comparison of several UPR markers enable to 
underscore the ability to selectively activate different arms of  the UPR. 
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3.MATERIALS AND METHODS 
 
3.1 Animals.  
 
We used male ICR CD-1 mice (5-weeks old, 29.6±0.3 g body weight at entry into 
the study). Animals were placed in the hypoxic chambers (Corno et al., 2002) and 
exposed to either 6.5% O2 (severe hypoxia), 10% O2 (moderate hypoxia) or 21% 
O2 (control) for 5 h (n=10/group). All animals had free access to water and 
conventional laboratory diet until 24 h before sacrifice. The investigation conforms 
to the Guide for the Care and Use of Laboratory Animals published by the National 
Institutes of Health (NIH Publication No. 85-23, revised 1996). At the end of 
hypoxia exposure, animals were transferred one-by-one into the procedure 
chamber kept at the same %O2 as the hypoxic chamber, anesthetized by i.p. Na-
thiopental (10 mg/100 g body weight) plus heparin (500 units) and sacrificed by 
cervical dislocation. Only after sacrifice, the animals were taken out of the chamber 
and dissected, heart and liver were rapidly excised and immersed in liquid 
nitrogen, the whole procedure taking <1 min after sacrifice. Thus, all organs were 
taken during hypoxia preventing reoxygenation. Organs were stored at -80°C until 
use.  
 
3.2 Isolation of RNA and quantitative real–time PCR.  
 
Total RNA was isolated using TRIZOL reagent (InVitrogen) according to the 
manufacturer’s recommendations. Reverse transcription was performed using 2 g 
of total RNA, oligo d(T) primer and 50 Units of AMV Reverse Transcriptase 
(InVitrogen). Quantitative PCR was performed using real-time detection technology 
and analyzed on a ABI prism 7500 Sequence Detector (Applied Biosystems) and 
relative quantification of gene expression was performed using the comparative 
threshold (Ct) method as described by the manufacturer. Power  SYBR green PCR 
master mix (Applied Biosystems)  and gene specific primers were used to 
analyzed mRNAs expression. The mouse actin beta gene was used as internal 
control to normalize the mRNA levels for each gene. Primers sequences are 
reported in Table1. 
 
                Table 1  
name 
 
            sequence 5'-3' 
 
PCR bp 
 
mCHOP for 
mCHOP rev 
 
mGADD34for 
GTGCATCTTCATACACCACCA 
CTCCTGCAGATCCTCATACC 
 
CTTCGCGAGCAGTCCGGA 
 
185 
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mGADD34rev 
 
mDerlin3 for 
mDerlin3 rev 
 
mXBP1 for 
mXBP1 rev 
 
mActinb for 
mActinb rev 
 
  mTRB3 for 
  mTRB3 rev 
GACAGGAGATAGAAGTTGTGG 
 
GCCACATCTACTACTTCCTAG 
CAGAGTGGGCTTCCTGCTC 
 
CCTTGTGGTTGAGAACCAGG3 
CTAGAGGTTGGTGTATAC 
 
CACCCACATAGGAGTCCTTC 
CAGTTCGCCATGGATGACG 
 
  CGAGTGAGAGATGAGCCTGA 
   CCCCATGGGTCTTCGTGAAA 
159 
 
 
184 
 
 
530 
 
 
171 
 
        180 
 
XBP1 splicing reaction was analized as published (Yoshida et al. 2003). XBP1 
PCR products were separated on 2% Nusieve3:1 agarose gel, followed by 
ethidium bromide staining and densitometric quantification of band intensities. 
Bands intensities were measured by the Gel Doc system. 
 
 3.3 Western Blotting  
 
Frozen tissues samples were lysed in potter homogenizer with a buffer containing 
10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT 0.2 mM PMSF, 
protease inhibitor cocktail (Sigma), 1 mM NaF, 100 nM Na orthovanadate. 
Samples were spun at 1200 rpm for 10 min to pellet nuclei. Nuclei were lyzed with 
a buffer with 20 mM HEPES pH 7.9, 1.5 mM MgCl2, 420 mM NaCl, 0.2 mM EDTA, 
25% glycerol, 0.5mM DTT, 0.2 mM PMSF, protease inhibitor cocktail, 1mM NaF, 
100 nM Na orthovanadate. Protein concentration was measured at 492 nm using 
the Coomassie Blue Reagent (Sigma). 
For the blot, 50 µg of lysate was separated on 10% PAGE under reducing 
conditions. Proteins were transferred to nitrocellulose filter (Amersham 
Biosciences) and blotted with p54-JNK, total-JNK, Bcl2 , Bax and Tubulin (Santa 
Cruz Biotecnology) antibodies. Proteins were visualized with ECL detection system 
(Amersham). 
 
3.3 TUNEL assay 
 
Apoptosis was assessed using the In Situ Cell Death Detection kit, TMR red 
(Roche), where the 3’-OH DNA ends, generated during DNA fragmentation, were 
labeled  with TMR red-nucleotides by the terminal deoxynucleotidyl transferase 
(TdT). The nuclei were then counterstained with Hoechst 33258 (Sigma).The 
slides were examined on a magnification of x 40 in an inverted fluorescence 
microscope (Axiovert 25 CFL, Zeiss, Gottingen, Germany) equipped with a filter for 
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the detection of rhodamine (filter set 15, excitation bandpass 546 +/- 12nm, 
emission 590 nm), or with a filter for Hoechst staining (Filter set 02, excitation 
bandpass 365, emission 420). The images were acquired by a digital camera 
system for microscopy (DS-5M); Nikon, Tokio, Japan). Two operators counted the 
number of TdT-labeled and total nuclei by examining at least 5 random fields in a 
blinded procedure. Results are expressed as number of TdT labeled nuclei/total 
nuclei/0.037 mm
2
. 
 
3.3  Statistics 
 
All data are expressed as mean±SEM. To assess significant differences among the 
groups, we first performed one-way ANOVA, then the Bonferroni multiple 
comparisons test if ANOVA was significant. The significance level was set to 
p<0.05. 
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4. RESULTS 
 
4.1 Acute hypoxia activates UPR in liver and myocardium 
  
To test whether the hypoxic insults activate the UPR pathway in vivo, mice were 
kept for 5 h either under 6.5% O2 or 10 % O2. All animals survived the treatment. 
Total RNA from liver and myocardium was extracted and the level of mRNA 
transcripts of CHOP and GADD34, which are known to be  induced during  ER 
stress in vitro and in vivo were measured. In liver tissue, the levels of CHOP  and 
GADD34 mRNA were induced 1.5  and 2,3 times respectively under 6.5% O2. In 
myocardium tissue, the levels of CHOP and GADD34 mRNAs did not change by  
hypoxia in vivo (Figure 10A and B). Next we measured the mRNA expression level 
of the human homolog of Drosophila tribbles (TRB3). TRB3 is induced by various 
form of endoplasmic reticulum stress as a part of the UPR signaling response 
(Jousse et al., 2007).  In hepatocytes TRB3 was expressed under normal 
conditions and its expression was augmented by 10% and 6.5% O2 by 4.7 and 
12.6 folds respectively. TRB3 was not expressed in steady state myocytes but was 
highly induced by 10% O2 (10 folds) and 6.5% O2 (92 folds), (Figure 10C). 
 The level of Derlin-3, a component of  the UPR pathway that is upregulated by 
accumulation of unfolded proteins and that promotes  ER-associated degradation 
(ERAD),  was induced at similar extent  in liver and myocytes of mice subjected to 
6.5% O2 (4.3 and 4.8 folds respectively, Figure 10D). As a whole, these results 
indicate that myocardium and liver tissues respond to limited O2 availability by 
activating the UPR genes.  Therefore the UPR response to in vivo hypoxia is 
tissue-specific and depends on the stress severity. 
We could not detect changes in eIF2 phosphorylation in hepatocytes and 
myocytes after hypoxic exposure at 10% and 6.5% O2  (data not shown). It has 
been reported that small changes as 20% in the phosphorylation levels of eIF2 
can dramatically suppress translation initiation (Kaufman, 2002), (Koumenis et al., 
2002). Moreover, it has been shown, using different cell culture systems, that 
severe hypoxia (<0.5% O2) causes a rapid phosphorylation of eIF2 followed by a 
partial recovery after 4-6 hours, consistent with the activation of a negative 
feedback loop. (Koumenis et al., 2002), (Koritzinsky et al., 2006). In contrast 
phosphorylation of eIF2 during moderate hypoxia (1% O2) requires long hypoxic 
exposures. In order to check for the activation of the PERK-dependent axis of the 
UPR we detected the expression level of the transcription factor ATF4 which is 
translationally upregulated in an eIF2 phosphorylation dependent manner.  Both 
10% O2 and 6.5 % O2 increase the expression of ATF4 in hepatocytes (Figure10E) 
consistent with the expression of CHOP.   
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Figure 10. Upregulation of the UPR markers in liver and myocardium tissues 
of mice exposed to hypoxia at the indicated % O2 for 5 h. A-D. Quantitative  
Real Time RT-PCR for CHOP, GADD34, TRB3 and Derlin3,  -actin gene cDNA is 
used as internal control. The graphs represent the average and standard 
deviations of triplicate real time reactions of two animals for each treatment. One-
way ANOVA* p<0.05 vs. 21%O2. E. Tissues lysates were separated in 5-15% 
PAGE and blotted with anti ATF4 and  actin specific antibodies. Graphs represent 
densitometry analysis of bands compared to protein levels in normoxic animals. 
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4.2 Acute hypoxic stress results in increased apoptosis, 
JNK phosphorylation and decreased Bcl2  
 
The TUNEL assay showed clear signs of DNA fragmentation in liver and 
myocardium after acute hypoxia (Figure 11). Both 10% and 6.5 % O2 resulted 
in 10-20 fold increase in the number of TUNEL-positive nuclei in liver and 
myocardium tissues.  
Because activated IRE1 has been shown to interact with the adaptor protein 
TRAF resulting in activation of apoptosis through C-Jun amino terminal kinase 
(JNK), we measured the level of JNK phosphorylation in the cytosolic 
fractions of hepatocytes and myocytes after the 5 h hypoxic stress. The 
quantitative densitometry of the blots shows that in liver tissue the level of 
p54-JNK protein was upregulated 1.5 fold in mice exposed to 6.5% O2 (Figure 
12). The level of the anti-apoptotic protein Bcl2 was reduced by 40% and  the 
Bcl2/Bax ratio was also reduced. In myocardium tissue, the level of p54-JNK 
protein was unaffected by hypoxia.  At 6.5% O2 Bcl2 decreased by 50% and 
the ratio  Bcl2/Bax was reduced at 50% as well. This shows that hypoxic 
stress changes the balance between pro-apoptotic and anti-apoptotic proteins 
in tissue-specific manners. 
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Figure 11. Apoptosis by TUNEL assay of myocardium and liver 
tissues of mice exposed to hypoxia at the indicated % O2 for 5 hours. 
The apoptotic nuclei are dyed with tetramethyl- rhodamine. The graph 
indicates the ratio between TUNEL positive nuclei and total nuclei number 
in 0.037 mm2 (meanSEM, n=6 per group). One-way ANOVA p<0.001 and 
0.002 for liver and myocardium, respectively. * p<0.05 vs. 21%O2 
(Bonferroni post-test). 
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Figure 12. Effect of 5 h hypoxia on apoptotic proteins in liver and 
myocardium. Tissues lysates were separated in 10% PAGE and blotted 
with specific antibodies. Graphs represent densitometry analysis of bands 
compared to protein levels in normoxic animals (meanSEM, n=6 per 
group). One-way ANOVA p<0.01 and 0.02 for liver and myocardium, 
respectively. * p<0.05 vs. 21%O2, # , p<0.05%vs.10% O2 (Bonferroni post-
test), 
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4.3 Hypoxia does not activate  XBP-1-splicing 
 
The IRE-1-dependent branch of the UPR involves splicing of 26 nucleotides from 
the mRNA of the XBP-1 gene (Bertolotti and Ron, 2001; Lee et al., 2002; Liu et al., 
2002). In turn, this event results in translation of the XBP-1 gene to produce a 
factor that regulates the transcription of proteins involved in the UPR signaling 
pathway (Urano et al., 2000). We investigated the effect of hypoxia on XBP-1 
mRNA splicing using a PCR-based assay. Figure 13 shows that the level of spliced 
XBP-1 was undetectable in both liver and myocardium tissues of mice treated with 
either 10% or 6.5% O2 for 5 h indicating that hypoxic stress does not induce XBP-1 
splicing. 
 
Figure 13.  Analysis of XBP-1 splicing in liver and myocardium from mice 
exposed to 10% or 6.5% O2. The PCR products of two samples per group are 
shown. As a control, HEPG2 cells were incubated for 5 h with 5 µg/ml of 
tunicamicin, a strong inducer of the UPR.  
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5. DISCUSSION 
 
5.1 Unfolded proteins and hypoxia 
 
We studied the role of hypoxia on UPR signaling pathway in vivo. Giving the 
heterogeneity of oxygen availability in  organs,  we hypothesized that   different 
tissues  may respond  to  hypoxic insults  by activating specific arms of UPR 
signaling. At the same time we aimed to use more physiologically relevant models 
than the early literature and  paid special attention to study the molecular events  
and signaling pathways  activated when animal are exposed to low  O2 levels. 
Our overall results are consistent with the literature reports on activation of the 
UPR in cell culture grown under hypoxic conditions, at the same time give new 
insights about the oxygen-dependent  activation of specific branches of the UPR in 
different tissues.  
In this study, animals were exposed to varying degrees of hypoxia and sacrificed 
without reoxygenation. Therefore, the presented data are free of possible artifacts 
due to the presence of reactive O2 species that may disturb the UPR pathway, and 
the direct effect of hypoxia is thus emphasized. As hepatocytes and 
cardiomyocytes are from relatively homogeneous organs, whole cell and RNA 
extracts well represent the behavior of the organ to which they belong. Whereas 
the myocardium is an organ with high O2 demand that quickly overexpresses HIF-
1 within 1 h of hypoxia (Caretti et al., 2007), the liver is perfused for 80% with low-
PO2 portal venous supply. Thus, by ranging from 44.45.1 mmHg in sinusoids to 
4.51.3 mmHg across the lobus (James et al., 2002), liver tissue PO2 is rather low, 
and the liver may be considered a permanently hypoxic organ that has dismissed 
its ability to accumulate HIF-1 (Bianciardi et al., 2006). Therefore, liver and 
myocardium tissues widely diverge for their O2 metabolism and can be taken as 
extreme paradigms that encompass most of the other organs. 
Our experiments show that 6.5% O2 reduction results in induction of CHOP and 
GADD34 transcripts, and translation of ATF4 downstream of the PERK-axis 
(Figure 10) in hepatocytes. Severe hypoxia in liver results also in activation of  the 
cell death signaling pathway dependent from the IRE1 branch of the UPR, as the 
increase of  p-JNK (Figure 13). It has been known that upregulation of CHOP 
promotes cell death (McCullough et al., 2001), whereas CHOP deletion protects 
against the death of ER stressed cells (Zinszner et al., 1998), (Oyadomari et al., 
2002).  These observations suggest that CHOP evolved to link insurmountable 
levels of ER stress to the cell-death machinery. Furthermore, CHOP has been 
reported to inhibit the expression of Bcl2 (McCullough et al., 2001) and directly 
activate the proapoptotic death receptor 5 protein, which recruits procaspase-8 to 
form a death-inducing signaling complex. IRE1 has been reported to induce the 
proapoptotic signaling via its kinase domain, which can activate the adaptor protein 
TRAF2 and the downstream effector kinase p-JNK (Nishitoh et al., 1998) (Nishitoh 
and Ichijo, 2004). 
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All together these results suggest that the liver is able to activate the PERK-
dependent arm of the UPR during hypoxia in order to balance both the attenuation 
of protein synthesis and apoptosis.  Liver and myocardium tissues have different  
rate of protein synthesis, being higher in hepatocytes, that are able to produce 
elevated levels of secretory proteins, than in myocardium. However, while the liver 
can regulate protein synthesis and inhibition according to its own physiological 
needs  and energy demands, the myocardium  is resistant to suppression of 
protein synthesis (Yuan et al., 2008).  
TRB3 is a UPR-induced gene whose expression is upregulated by CHOP and 
ATF4 transcription factors. Moreover, experiments of overexpression of TRB3 
have shown that is able to reduce the levels of CHOP and GADD34 mRNA (Ord et 
al., 2007), suggesting that TRB3 acts as a negative feedback regulator of the 
ATF4-CHOP dependent transcription (Ohoka et al., 2005), (Jousse et al., 2007), 
(Su and Kilberg, 2008). Although the exact mechanism by which TRB3 inhibits the 
transcriptional activation of ATF4 remains obscure, it has been proposed that 
TRB3 inhibits ATF4 and CHOP by interfering with the recruitment of cofactors of 
the transcriptional apparatus.(Ord et al., 2007)  
Since CHOP and ATF4 are induced by many ER stress signals, as oxidative 
stresses, amino acid deprivation and hypoxia, it is possible that the CHOP-TRB3 
pathway operates in response to these stresses as well. Indeed, it has been 
reported that TRB3 is induced in in vitro models of hypoxia and  ischemia (Bowers 
et al., 2003), (Avery et al., 2010). Here we show that TRB3 expression is 
significantly upregulated by 10%  and 6.5 % O2 in vivo in liver and myocardium and 
is a sensitive marker of hypoxic-stress, however its function in hypoxic tissues 
remains to be clarified. It has been proposed that TRB3 could be the sensor for ER 
stress-induced apoptosis. If the ER stress is transient and mild, the induced TRB3 
blocks the CHOP and ATF4 functions by binding to them, however, when potent 
and prolonged ER stress occurs, TRB3 leads to apoptosis (Ohoka et al., 2005).  
Derlin 3 is an ATF6-regulated protein member of the Derlins family genes. Like the 
homologous Derlin 1 and 2, Derlin 3 is induced by ER stress in several cell types 
(Oda et al., 2006). In a recent study it has been found that Derlin 3 was induced by 
ATF6 in vivo and in cultured cardiac myocytes. Derlin3 was also induced in the 
infarct border zone in an in vivo mouse model of myocardial infarction and 
published results suggest that Derlin 3 may have a protective role in the heart 
(Belmont et al., 2010). In our experimental conditions Derlin 3 is induced at similar 
extent in liver and myocardium by hypoxia. Moreover, to our knowledge this is the 
first report of upregulation  of Derlin 3 under hypoxic stress. Since Derlin 3 
transcription has been shown to be under the control of ATF6 (Belmont et al., 
2010), our results suggest that the ATF6 branch of the UPR is activated by 
hypoxia, although further in vitro experiments must confirm our finding. 
Our in vivo experiments could not detect XBP-1 splicing in liver and myocardium 
after 5 h of O2 reduction, independently from the severity of the hypoxic insult. 
Attempts to understand the time frame of UPR pathway activation has elucidated 
that mammalian cells are able to execute a time-dependent phase-transition from 
protein translational attenuation to protein degradation depending on the quantity 
of misfolded proteins accumulated in the ER (Yoshida et al., 2003). It is possible 
that the level of accumulated misfolded proteins after hypoxic insults does not 
reach a threshold necessary for activating this arm of the UPR. To corroborate our 
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finding, XBP1 splicing has been detected in tumor cells grown in vitro only under 
severe hypoxia (<0.1% O2) (Koumenis et al., 2002). 
Given the detection of CHOP and JNK activation in liver it seems that the 
activation of the PERK-dependent signaling pathway is the first answer to acute 
hypoxia in liver. These results suggest that upon UPR stress hepatocytes (which 
are self renovating cells) balance between attenuation of translation and apoptosis. 
The TUNEL assay highlights the multitude and complexity of apoptotic pathways 
activated when oxygen availability becomes low, some of them can be traced to 
ER stress while others may be activated by different insults (Xu et al., 2005). 
From the data illustrated in this study and from literature reports, we can propose 
the following scheme shown in Figure 14 where 6.5% O2 reduction activates all the 
three branches the UPR pathway in liver. While the hepatocytes activate the 
apoptotic pathway mediated, in part, by CHOP and p-JNK, we could not detect an 
UPR-dependent apoptosis in myocytes, moreover  in the myocardium the ATF4-
CHOP-GADD34 signaling pathway  is not detectably activated and the protein 
synthesis remain sustained under low oxygen availability. 
 
Figure 14. Activation of the unfolded proteins response (UPR) pathway 
following hypoxic stress. Upon accumulation of misfolded proteins, the 
BiP/GRP78 is released from cognate transmembrane receptors. As a first 
consequence PERK is activated and phosphorylates the α subunit of eukaryotic 
translation initiation factor 2 (eIF2) on Ser
51
. The transcription factor CHOP, the 
anti apoptotic protein Bcl2, the phosphatase GADD34 and TRB3 are activated. 
The inositol-requiring protein 1 (IRE1) cytoplasmic domain interacts with the 
adaptor protein TRAF2 that couples c-Jun activation linking ER stress to 
apoptosis. The transmembrane UPR-sensor ATF6 is cleaved and the 
cytoplatsmatic portion, liberated from its transmembrane tether, can bind to DNA 
and promote transcription of ER associated degradation  genes as Derlin 3. This 
activation cascade is modulated by the intensity of ER stress and, as 
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consequences, by the amount of misfolded protein accumulated. Genes and 
effectors pathways activated in liver are depicted in green, in red when activated 
in myocardium. 
 
 
5.2 Toward a model of proteostasis network 
Understanding how the unfolded polypeptides, resulting from the process of 
translation, arrive at their native structures for function and how these structures 
are maintained and ultimately turned over is a major challenge in biology. 
Furthermore we need to progress toward translating these insights into meaningful 
improvements in the diagnosis and treatments of many diseases associated with 
protein misfolding. Unlike protein folding in a tube, a protein in a eukaryotic cell 
must fold and function in a crowded environment. Moreover proteins are subjected 
to extensive changes in structure, as they cycle between  inactive and active 
conformations, and/or they engage in the protein-protein interactions. We now 
recognize that the chemical and energetic properties specified by the amino acid 
sequence of a polypeptide, (the primary structure), encoded by the genome, while 
very important in partially determining the folding energy landscape, are only part 
in determining  how proteins evolve biological functions. Numerous 
macromolecular assistants exist in the cells to influence the folding of the 
proteome, such assistance controls the rate of protein synthesis, influences the 
rate of folding, affects membrane trafficking and compartmental localization, 
mitigates aggregation and mediates degradation, enabling protein turnover. These 
competing biological pathways, comprising hundreds of components, make up the 
proteostasis (protein homeostasis) network (Balch et al., 2008). 
Proteostasis refers to controlling the concentration, conformation, binding 
interaction (quaternary structure), and location of individual proteins making up the 
proteome by readapting the innate biology of the cell, often trough transcriptional 
and translational changes. The proteostasis is influenced by the chemistry of 
protein folding /misfolding and by numerous regulated networks of interacting and 
competing biological pathways. 
The proteostasis network and its pathways are controlled by numerous integrated 
signaling events that optimize the capacity of the proteostasis to network and 
maintain protein function. This occurs by more efficiently folding the natively folded 
proteins and maintaining the unstructured cellular proteins in a non aggregated 
state. The proteostasis network is ancient, furthermore coevolved with the 
remarkable diversity of polypeptide sequences to enable the evolution of a wide 
variety of organisms by expanding the capacity of proteins to function in 
increasingly complex cellular and subcellular environments, and to perform 
increasingly specialized cellular tasks. 
It is the job of the cellular proteostasis network to enable cellular protein folding 
and function, in the face of all the challenges discussed above. The proteostasis 
network consists of numerous biological pathways that comprise chaperones, 
folding enzymes, degradation and trafficking components.  Control of the 
proteostasis network is accomplished by signaling pathways that directly regulate 
the concentration, distribution and activities of the different components of the 
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proteostasis network itself (Morimoto, 2008), (Young et al., 2004). Different cells 
have varying proteostasis capacities reflected in the composition and 
concentrations of their proteostasis components, presumably to handle the 
different folding challenges that arise in response to differentiation during 
development. 
Numerous factors influence the properties of the proteostasis network including 
changes in intracellular ATP levels, amino acids pools, metabolites, lipid 
homeostasis, and ion balance. These not only alter folding capacity, but also 
modulate the activity of a number of other proteostasis network pathways such as 
the degradative pathways, protesomal, lysosomal and autophagic, that are integral 
to maintenance of proteostasis (Konstantinova et al., 2008), (Tasaki and Kwon, 
2007), (Levine and Kroemer, 2008), (Kundu and Thompson, 2008). 
The experimental work described in this thesis aimed at delineating  the 
proteostasis network of the ER by analyzing the heterogeneity ER of stresses and 
fine tuning of the UPR  in different cellular conditions. 
In chapter 1.2.1 we elucidated the relationship between unfolded protein 
accumulation in the ER lumen and ER stress, by analyzing  the folding 
requirements and chaperones interaction of coagulation FVIII a large glycoprotein 
that is known to be prone to misfolding in the ER lumen even in its wild type form. 
Its expression provides a unique approach to study and manipulate the ER stress 
response that does not rely on pharmacological intervention. 
Our  results support that the level of cellular energy is important for protein folding 
and for disaggregation of  transient aggregates within the ER. By contrast, in our 
hands,  inhibition of proteasomal degradation did not result in accumulation of high 
molecular weight FVIII aggregates within the cells, suggesting that the active 
proteasome is not required for their removal  and that these transiently formed 
aggregates may be rescued for secretion. 
The proteostasis network is not only highly adaptable, enabled by the influence of 
multiple cell stress signaling pathways, but also can be quite distinct in each cell 
type. This is not surprising giving the central role of proteins in cell physiology and 
the diversity of cell functions. The response to diversification includes proteostasis 
network components that are conserved throughout evolution and those that are 
specialized. For example, hepatocytes, plasma cells and  cells must produce high 
levels of distinct secreted proteins, whereas fibroblasts have less secretory activity, 
and therefore a less specialized ER proteostasis network capacity. That suggests 
that a protein ability to achieve its functional state is dependent on the proteostasis 
network. Thus any effort to understand protein folding, and therefore protein 
function in vivo, will need to consider the interdependence between the folding 
energetic and the proteostasis network. 
In chapter 1.2.2   we studied the plasma cells differentiation and death, which 
involves the stepwise synthesis of different classes of proteins as to increase the 
secretory capacity and thus the proteostasis network of the cell. In particular, our 
studies have investigated the contribution of UPR signaling and degradative 
pathways to B-cell development. Our and other’s results underline the role of the 
UPR signaling and proteasomal degradation in orchestrating the architectural and 
functional changes during terminal plasma cell differentiation. 
The use of proteasome inhibitors in clinical approach illustrates the value of 
manipulating the proteostasis boundary to promote cell death. Proteasome 
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inhibitors decrease the degradation rate of misfolded proteins thus resulting in 
increased concentration of misfolded proteins, that likely saturates the proteostasis 
network, so that cells cannot sustain cell viability. In multiple myeloma, the 
proteasome inhibitor Boterzomib selectively kills the cancerous plasma cells that 
produce large amounts of immunoglobulin. This selectivity arises because 
myeloma cells are already challenged with a high protein folding load, and 
proteasome inhibitor further diminishes the capacity of the proteostasis network to 
maintain cells functional. Our results suggest that the unfavorable load-capacity 
ratio in Ig-secreting cells could make the latter more prone to enter apoptosis, 
either basally or following treatment with proteasome inhibitors. Moreover, our 
findings have important implication related to the potential utilization of proteasome 
inhibitors in the treatment of inflammatory disorders, especially those related to 
excessive antibody production. 
Activation of ER stress sensors after hypoxic insults strongly suggests that lack of 
O2 perturbs ER homeostasis. Although the direct requirement for O2 in ER function 
remains to be clarified in detail,  the ER has emerged as a cellular compartment 
that depends on O2 for oxidative folding of secretory and transmembrane proteins 
and that mediates the O2 signaling that is important for the survival and function of 
hypoxic cells. 
In chapter 4 we analyzed the effect of hypoxia  as a physiologic stressor  that 
affects the proteostasis in  vivo. We considered the possibility that changes in the 
cellular oxygen availability correspond in changes in the proteostasis network 
components. 
Both hepatocytes and myocytes respond to hypoxia by increasing their 
degradation activity  as to increase the proteostasis capacity of hypoxic cells.  At 
the same time hepatocytes are able to activate the PERK-dependent axis of the 
UPR that results in attenuation of protein translation. 
Attenuation of protein synthesis following hypoxic insults  is primarily due to a HIF-
independent oxygen sensing pathway that directly inhibits the initiation step of 
mRNA translation. Inhibition of translation during hypoxia is important for its ability 
to both promote cell survival and to alter gene expression and cell phenotype.  A 
general suppression of mRNA translation can also induce important changes in 
protein expression, due to differences in protein half-life, and allow to reset  the 
proteostasis network. Furthermore, proteome changes are expected due to the fact 
that not all the mRNA transcripts are affected to the same degree. Finally, because 
translation efficiency can be rapidly modulated, this mechanism allows for much 
faster protein turnover that is possible through changes in transcription. 
Experiments performed with cell lines exposed to  severe (<0.05% O2) and 
moderate (0.2-1% O2) hypoxia have shown  inhibition of protein translation through 
eIF2 phosphorylation  and thus dependent from the activation of the PERK kinase 
which regulates a branch of the  UPR signaling pathway (Koumenis et al., 2002).   
Interestingly, the ability to attenuate protein synthesis through the eIF2-
dependent phosphoryltion and translation of ATF4 appears to be a prerequisite of 
hepatocytes  One of the fundamental differences between liver and myocardium 
tissues is the rate of protein synthesis, being higher in liver, that is able to produce 
elevated levels of secretory proteins, than in myocardium. However, while the liver 
can regulate protein synthesis and inhibition according to its own physiological 
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needs  and energy demands, the myocardium  is resistant to suppression of 
protein synthesis. 
Although activated independently growing evidence suggest that HIF, and UPR-
dependent response to hypoxia act in an integrated way, influencing each other 
and generating different signaling outputs that can be tailored to various cell types  
and physiological situations in order to modify the cellular proteostasis network. 
Further experiments must be performed using different transgenic models in order 
to understand which proteins are selectively induced during hypoxic insults when 
mechanisms of translational attenuation are activated. 
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6. CONCLUSIONS 
 
In conclusion our studies could underline several features of the ER- homeostasis  
- First the level of oxygen availability can influence the proteostasis capacity of 
the ER in vivo by activating some branches of the UPR signaling pathway. 
- Second the proteostasis network is adaptable and able to fine tune the UPR 
signaling pathway in response to the stress intensity. Moreover different cells 
have varying proteostasis capacities reflected in the composition and 
concentrations of their proteostasis components 
- Third, the cellular energy levels affect protein folding as well as protein 
disaggregation and thus mediate folding and repair process. The proteasome 
activity, by mediating protein degradation, can  balance the proteostasis 
capacity of the cell.   
This work also illustrates the complexity of the proteostasis network  for cell 
homeostasis. The cellular capabilities to manage excess of protein folding load are 
limited and therefore, by setting the proteostasis boundary as a threshold for 
generating folded and functional proteins, the proteostasis network can create and 
maintain functional proteins in response to the local environment. 
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6.1 Implications 
 
Signaling pathways that regulate protein synthesis, folding, trafficking, aggregation, 
disaggregation and degradation include the UPR, which principally influence the 
ER folding capacity (Malhotra and Kaufman, 2007), (Ron and Walter, 2007), the 
heat shock response (HSR), which balance proteostasis capacity in the cytosol 
(Shamovsky and Nudler, 2008), pathways that influence subcellular Ca
++
 
concentrations (Petersen et al., 2005), (Burdakov et al., 2005), the inflammatory 
response, which regulate cell defense (Medzhitov, 2008), (Zhang and Kaufman, 
2008) and histone deacetylase (HDAC), which integrate proteostasis capacity 
through epigenetic pathways (Fig 15). Such signaling events control the capacity 
and composition of the proteostasis network through transcriptional, translational 
and posttranslational mechanisms to balance proteostasis by reducing demand, 
enhancing folding and repair processes, and mediating degradation. When 
proteostasis is severely compromised, cell death pathways are activated targeting 
the cell for destruction. 
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Fig. 15   managing proteostasis. The proteostasis network is composed of the 
components outlined in the first layer (red font), including the ribosomes, 
chaperones, aggregates and disaggregates that influence folding, as well as 
pathways that select proteins for degradation [ the ubiquitin-proteasome system 
(UPS), endoplasmic reticulum-associated degradation (ERAD) system, proteases, 
autophagic pathways, lysosomal/endosomal pathways and phagocytic pathways, 
the latter responsible for the recognition, uptake and degradation of extracellular 
proteins]. The second layer includes signaling pathways (green font) that influence 
the activity of component found in the first layer. The third layer (blue font) includes 
genetic and epigenetic pathways, physiological stressors, and intracellular 
metabolites that affect the activity defined by the first and second layers. From: 
Powers et al Annu. Rev. Biochem. 2009 
 
 
When a protein fails to fold properly owing to an alteration in its sequence (a DNA 
sequence mutation), an aberrant posttranslational modification, or when a 
misfolding-prone protein is overexpressed, or the composition of the components 
of the proteostasis network becomes deficient, cells have to face  stressful 
conditions. Loss of protein function, or gain of toxic function (the latter often being 
associated with aggregation) can trigger disease by interfering with this cellular 
function. The multiple role of the proteostasis network in maintaining the proteome 
and, therefore, normal physiology in response to challenges during development, 
aging and stress are only beginning to be appreciated. 
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To better understand  how the protein folding system and the proteostasis network 
interact and influence the folding efficiency of a given protein, mathematical 
models have been proposed wherein protein folding energetic and proteostasis 
network components and concentrations are the variable (Powers et al., 2009). 
Furthermore, the concept of proteostasis boundary, that is the folding energetic 
required to achieve folding of a protein at a given proteostasis network capacity, 
has been introduced to illustrate what can go wrong in proteostasis diseases. Thus 
the detailed knowledge of the proteostasis of the  endoplasmic reticulum and the 
activation of the unfolded protein response pathway in vivo 
are important in order to progress toward translating these insights into meaningful 
improvements in the diagnosis and treatments of many diseases associated with 
protein misfolding 
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